Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Biometry Research Group

Publications

View All  |  2014-2010  |  2009-2000  |  1999-1990  |  1989-1980  |  1979-1970

2014

  • Adams KF, Leitzmann MF, Ballard-Barbash R, Albanes D, Harris TB, Hollenbeck A, Kipnis V. Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol. 2014 Jan 15;179(2):135-44. 2013 Oct 29 [epub ahead of print].
    [ PubMed Abstract ]
  • Baker, SG. Comparative analysis of biologically relevant response curves in gene expression experiments: heteromorphy, heterochrony, and heterometry. Exit Disclaimer Microarrays 2014, 3, 39-51.
  • Baker SG. Instrumental variable methods for causal inference: early work and recent developments. Statistics in Medicine. 2014; 33(17), 3058–3059.
    [ PubMed Abstract ]
  • Baker SG. Principal stratification: all-or-none versus partial compliance. Letter to the Editor. Clinical Trials. 2014; 11, 380-1.
    [ PubMed Abstract ]
  • Baker, SG. Recognizing paradigm instability in theories of carcinogenesis. Exit Disclaimer British Journal of Medicine and Medical Research. 2014 (4)1149-63.
  • Baker SG, Kramer BS, Lindeman KS. The randomized registry trial. N Engl J Med. 2014 Feb 13;370(7):681-2.
    [ PubMed Abstract ]
  • Baker SG, Schuit E, Steyerberg EW, Pencina MJ, Vickers A, Moons KGM, Mol, BWJ, Lindeman KS. How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through. Statistics in Medicine. 2014; 33(2) 3946–3959. Correction 33(2): 3960.
    [ PubMed Abstract ]
  • Baker SG, Xu J, Hu P, Huang P, Vardeman SB, Morris MD. Majority voting by independent classifiers can increase error rates. The American Statistician. 2014;67, 94-96. Comment by Baker, Xu, Hu, and Huang in The American Statistician. 2014;68:125-6.
  • Pepper JW, Dunn BK, Fagerstrom RM, Gohagan JK, Vydelingum NA. Using systems biology to understand cancer as an evolutionary process.Exit Disclaimer Journal of Evolutionary Medicine. 2014 (2)1-8.

2013

  • Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J for the National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013 Sep 5;369(10):920-31.
    [ PubMed Abstract ]
  • Baker SG. Additional thoughts on causal inference, probability theory, and graphical insights. Exit Disclaimer Stat Med. 2013 (32) 4334-37.
  • Baker SG. Causal inference, probability theory, and graphical insights. Stat Med. 2013 May 10.
    [ PubMed Abstract ]
  • Baker SG. Letter to the editor: Comment on Hubbard and Miglioretti (2013). Consider also a selection model for the cumulative risk of false positive screening tests. Biometrics. 2013 Dec;69(4):1084.
    [ PubMed Abstract ]
  • Baker SG. Letter to the editor: The tangent classifier. The American Statistician 2013;67:64-65.
  • Baker SG. Paradox-driven cancer research. Exit Disclaimer Disruptive Science and Technology. 2013 1(3): 143-48.
  • Baker SG. Recognizing paradigm instability in theories of carcinogenesis. Exit Disclaimer British Journal of Medicine and Medical Research. Nov 8, 2013.
  • Baker SG. Remarks on "A simple decision analytic solution to the comparison of two binary diagnostic tests" by Vickers et al." Stat Med 2013;32(4):718.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Surrogate endpoint analysis: an exercise in extrapolation. J Natl Cancer Inst 2013;105(5):316-320.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. The risky reliance on small surrogate endpoint studies when planning a large prevention trial. Journal of the Royal Statistical Society, Series A 2013;176(2):603-608.
    [ PubMed Abstract ]
  • Baker SG, Lindeman K. L Revisiting a discrepant result: a propensity score analysis, the paired availability design for historical controls, and a meta-analysis of randomized trials. Exit Disclaimer British Journal of Causal Inference. 2013 1(1):51-82.
  • Berger VW. On the insufficiency of reporting masking. J Rehabil Med 20 13;45(2):221-222.
    [ PubMed Abstract ]
  • Berger VW. Reply to Letter-to-the-Editor: Efficacy and degree of bias in knee injury prevention studies: a systematic review of RCTs. Clin Orthop Relat Res 2013;471(1):341-342.
    [ PubMed Abstract ]
  • Major JM, Graubard BI, Dodd KW, Iwan A, Alexander BH, Linet MS, Freedman DM. Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. J Clin Endocrinol Metab 2013;98(1):97-104.
    [ PubMed Abstract ]
  • Mir MC, Stephenson AJ, Grubb RL 3rd, Black A, Kibel AS, Izmirlian G. Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2241-9.
    [ PubMed Abstract ]
  • Murad H, Kipnis V, Freedman LS. Estimating and testing interactions when explanatory variables are subject to non-classical measurement error. Stat Meth Med Res. 2013 Dec 11 [epub ahead of print].
    [ PubMed Abstract ]
  • Palys KE, Berger VW. Re: Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review. J Natl Cancer Inst 2013;105(3):244-245.
    [ PubMed Abstract ]
  • Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN. Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the Prostate, Lung, Colorectal, and Ovarian Screening Trial. Obstet Gynecol 2013;121(1):25-31.
    [ PubMed Abstract ]
  • Pepper JA, Vydelingum NA, Dunn BK, Fagerstrom RM: Agent-Based Models in Cancer Prevention Research; in Agent-Based Models: Theory, Developments & Applications Exit Disclaimer, (pp 105-116) . Nova Science Publishers, Hauppauge, New York.
  • Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013 Aug 26.
    [ PubMed Abstract ]
  • Rosenfeld S. Are the somatic mutation and tissue organization field theories of carcinogenesis incompatible? Cancer Inform. 2013 Dec 1;12:221-9.
    [ PubMed Abstract ]
  • Rosenfeld S. Global consensus theorem and self-organized criticality: unifying principles for understanding self-organization, swarm intelligence and mechanisms of carcinogenesis. Gene Regul Syst Bio. 2013;7:23-39.
    [ PubMed Abstract ]
  • Subar AF, Midthune D, Tasevska N, Kipnis V, Freedman LS. Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr. 2013 Aug;67(8):863-7.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team. Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013 May 23;368(21):1980-91.
    [ PubMed Abstract ]
  • Van Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures. Med Decis Making. 2013 May;33(4):490-501.
    [ PubMed Abstract ]
  • Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B. Who should be included in a clinical trial of screening for bladder cancer?: A decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer 2013;119(1):143-149.
    [ PubMed Abstract ]

2012

  • Aktipis CA, Maley CC, Pepper JW. Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) 2012;5(2):266-275.
    [ PubMed Abstract ]
  • Anderson CM, Burns DM, Dodd KW, Feuer EJ. Chapter 2: Birth-cohort-specific estimates of smoking behaviors for the U.S. population. Risk Anal 2012;32 Suppl 1:S14-24.
    [ PubMed Abstract ]
  • Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia C, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC, and for the PLCO Project Team. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104(2):125-132.
    [ PubMed Abstract ]
  • Badurdeen DS, Umar NA, Begum R, Sanderson AK 2nd, Jack M, Mekasha G, Kwagyan J, Smoot DT, Laiyemo AO. Timing of procedure and compliance with outpatient endoscopy among an underserved population in an inner-city tertiary institution. Ann Epidemiol 2012;22(7):531-535.
    [ PubMed Abstract ]
  • Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, Dodd KW, Sempos CT, Betz JM, Picciano MF. Serum unmetabolized folic acid in a nationally representative sample of adults =60 years in the United States, 2001-2002. Food Nutr Res 2012;56.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Evaluating a new marker for risk prediction: decision analysis to the rescue. Discov Med 2012;14(76):181-188.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Sargent DJ, Bonetti M. Biomarkers, subgroup evaluation, and clinical trial design. Discov Med 2012;13(70):187-192.
    [ PubMed Abstract ]
  • Baker SG, Sargent DJ, Buyse M, Burzykowski T. Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time. Biometrics 2012;68(1):248-257.
    [ PubMed Abstract ]
  • Baker SG, Van Calster B, Steyerberg EW. Evaluating a new marker for risk prediction using the test tradeoff: an update. Int J Biostat 2012;8(1):article 5.
    [ PubMed Abstract ]
  • Baker SG. Comment on Nie et al. (2011), biometrics, early view. Biometrics 2012;68(3):992.
    [ PubMed Abstract ]
  • Baker SG. Gene signatures revisted. J Natl Cancer Inst 2012;104(4):262-263.
    [ PubMed Abstract ]
  • Baker SG. Paradoxes in carcinogenesis should spur new avenues of research: an historical perspective. Journal of Disruptive Science and Technology 2012;1(2):100-107.
  • Berger VW, Izmirlian G, Knoll D. Discussion of the paper of Ghosh, Taylor, and Sargent. Biometrics 2012;68(1):239-241.
    [ PubMed Abstract ]
  • Berger VW, Palys K. Medical research: what is wrong with this picture? The International Journal of Person Centered Medicine 2012;2(4):707-715.
  • Berger VW. Conservative handling of cluster randomized trials. Clin Trials 2012;9(3):371.
    [ PubMed Abstract ]
  • Berger VW. Conservative handling of missing data. Contemp Clin Trials 2012;33(3):460.
    [ PubMed Abstract ]
  • Berger VW. Conservative handling of missing information. J Clin Epidemiol 2012;65(11):1237-1238.
    [ PubMed Abstract ]
  • Berger VW. De facto masking and other measures to prevent contamination. J Clin Epidemiol 2012;65(11):1236.
    [ PubMed Abstract ]
  • Berger VW. Internal validity and the risk of bias: a case for a comprehensive review. J Anesth 2012;26(5):802-803.
    [ PubMed Abstract ]
  • Berger VW. Keep digging until we get the result we want? Contemp Clin Trials 2012;33(1):12.
    [ PubMed Abstract ]
  • Berger VW. Out of the frying pan and into the fire? Biometrics 2012;68(3):990.
    [ PubMed Abstract ]
  • Berger VW. Two-stage randomized trials: outstanding issues. Stat Med 2012;31(29):4142; author reply 4143-4144.
    [ PubMed Abstract ]
  • Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, Murphy G, Laiyemo AO, Wang Z, Cross AJ, Schatzkin A, Danta M, Srasuebkul P, Amin J, Law M, Breit SN, Lanza E. Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev 2012;21(2):337-346.
    [ PubMed Abstract ]
  • Carroll RJ, Midthune D, Subar AF, Shumakovich M, Freedman LS, Thompson FE, Kipnis V. Taking advantage of the strengths of 2 different dietary assessment instruments to improve intake estimates for nutritional epidemiology. Am J Epidemiol 2012;175;(4):340-347.
    [ PubMed Abstract ]
  • Dodd KW, Midthune D, Kipnis V. Re: "Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements". Am J Epidemiol 2012;175(1):84-85.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Major JM, Schootman M, Lian M, Park Y, Graubard BI, Hollenbeck AR, Sinha R. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer 2012;118(14):3636-3644.
    [ PubMed Abstract ]
  • Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, Sinha R, Allison J. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst 2012;104(18):1353-1362.
    [ PubMed Abstract ]
  • Doubeni CA, Schootman M, Major JM, Stone RA, Laiyemo AO, Park Y, Lian M, Messer L, Graubard BI, Sinha R, Hollenbeck AR, Schatzkin A. Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health 2012;102(4):680-688.
    [ PubMed Abstract ]
  • George SM, Thompson FE, Midthune D, Subar AF, Berrigan D, Schatzkin A, Potischman N. Strength of the relationships between three self-reported dietary intake instruments and serum carotenoids: the Observing Protein and Energy Nutrition (OPEN) Study. Public Health Nutr 2012;15(6):1000-1007.
    [ PubMed Abstract ]
  • Higgins AY, Doubeni AR, Phillips KL, Laiyemo AO, Briesacher B, Tjia J, Doubeni CA. Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study. BMC Gastroenterol 2012;12(1):23.
    [ PubMed Abstract ]
  • Jackson DS, Egbuonnu N, Umunakwe C, Fullum TM, Ford DH, Anders KB, McDonald-Pinkett S, Smoot DT, Laiyemo AO. Scheduled out-patient endoscopy and lack of compliance in a minority serving tertiary institution. Am J Med Sci 2012;344(3):194-198.
    [ PubMed Abstract ]
  • Kipnis V, Midthune D, Freedman LS, Carroll RJ. Regression calibration with more surrogates than mismeasured variables. Stat Med 2012;31(23):2713-2732.
    [ PubMed Abstract ]
  • Kirkpatrick SI, Dodd KW, Reedy J, Krebs-Smith SM. Income and race/ethnicity are associated with adherence to food-based dietary guidance among US adults and children. J Acad Nutr Diet 2012;112(5):624-635.
    [ PubMed Abstract ]
  • Kirkpatrick SI, Midthune D, Dodd KW, Potischman N, Subar AF, Thompson FE. Reactivity and its association with body mass index across days on food checklists. J Acad Nutr Diet 2012;112(1):110-118.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ. Obesity, weight change, and risk of adenoma recurrence: a prospective trial. Endoscopy 2012;44(9):813-818.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiol 2012;36(4):395-399.
    [ PubMed Abstract ]
  • Laiyemo AO. In search of a perfect solution to ensure that "no colon is left behind". Dig Dis Sci 2012;57(2):263-265.
    [ PubMed Abstract ]
  • Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J Proteomics 2012;75(15):4747-4757.
    [ PubMed Abstract ]
  • Palys K, Berger VW. On the need for competent evaluation of trial quality. Respir Med 2012;106(12):1804-1805.
    [ PubMed Abstract ]
  • Palys K, Berger VW, Grant W. Unequal allocation and allocation concealment. Stat Med 2012;31(29):4135-4136.
    [ PubMed Abstract ]
  • Pepper JW, Rosenfeld S. The emerging medical ecology of the human gut microbiome. Trends Ecol Evol 2012;27(7):381-384.
    [ PubMed Abstract ]
  • Pepper JW. Drugs that target pathogen public goods are robust against evolved drug resistance. Evol Appl 2012;5(7):757-761.
    [ PubMed Abstract ]
  • Pérez A, Zhang S, Kipnis V, Midthune D, Freedman LS, Carroll RJ. Intake_epis_food(): An R function for fitting a bivariate nonlinear measurement error model to estimate usual and energy intake for episodically consumed foods. J Stat Softw 2012;46(c03):1-17.
    [ PubMed Abstract ]
  • Perna FM, Oh A, Chriqui JF, Mâsse LC, Atienza AA, Nebeling L, Agurs-Collins T, Moser RP, Dodd KW. The association of state law to physical education time allocation in US public schools. Am J Public Health 2012;102(8):1594-1599.
    [ PubMed Abstract ]
  • Prorok PC, Miller AB, Kramer BS. Response: Re: Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104(10):793-794.
  • Raji OY, Duffy SW, Agbaje OF, Baker SG, David C. Christiani DC, Cassidy A, Field JK. Predictive accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer: a case-control and cohort validation study. Ann Intern Med 2012;157(4):242-250.
    [ PubMed Abstract ]
  • Roetzheim RG, Freund KM, Corle DK, Murray DM, Snyder FR, Kronman AC, Jean-Pierre P, Raich PC, Holden AE, Darnell JS, Warren-Mears V, Patierno S. Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Clin Trials 2012;9(2):176-187.
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Gastrointest Endosc 2012;75(3):612-620.
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld L, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, the PLCO Project Team. Colorectal cancer incidence and mortality in the PLCO Screening Trial. N Engl J Med 2012;366(25):2345-2357.
    [ PubMed Abstract ]
  • Tasevska N, Jiao L, Cross AJ, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Potischman N. Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. Int J Cancer 2012;130(1):159-169.
    [ PubMed Abstract ]
  • Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; for the PLCO Project Team. Flexible sigmoidoscopy in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: added yield from a second screening examination. J Natl Cancer Inst 2012;104(4):280-289.
    [ PubMed Abstract ]
  • Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS. Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer. Gynecol Oncol 2012;2012;125(1):70-74.
    [ PubMed Abstract ]
  • Xu J-L. A property of the generalized proportional hazards model. Far East Journal of Theoretical Statistics 2012;41(2):149-162.

2011

  • Alperson SY, Berger VW. Opposing systematic reviews: the effects of two quality rating instruments on evidence regarding T'ai Chi and bone mineral density in post-menopausal women. J Altern Complement Med 2011;17(5):389-395.
    [ PubMed Abstract ]
  • Andre F, McShane LM, Michiels S, Ransohoff DF, Altman DG, Reis-Filho JS, Hayes DF, Pusztai L. Biomarker studies: a call for a comprehensive biomarker study registry. Nat Rev Clin Oncol 2011;8(3):171-176.
    [ PubMed Abstract ]
  • Baker SG. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome: an alternative approach. Biometrics 2011;67(1):319-323; discussion 323-325.
    [ PubMed Abstract ]
  • Baker SG. Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res 2011;20(3):291-293.
    [ PubMed Abstract ]
  • Baker SG. TOFT better explains experimental results in cancer research than SMT. Bioessays 2011;33(12):919-921.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Systems biology and cancer: promises and perils. Prog Biophys Mol Biol 2011;106(2):410-413.
    [ PubMed Abstract ]
  • Baker SG, Lindeman KS, Kramer BS. Clarifying the role of principal stratification in the paired availability design. Int J Biostat 2011;7(1):Article 25.
    [ PubMed Abstract ]
  • Berger VW. Assessing the quality of surgical trials: further insight. Annals of Surgery 2011;253(2):420-421.
    [ PubMed Abstract ]
  • Berger VW. Assessing the success of masking in acupuncture trials: further insight. Chin J Integr Med 2011;17(7):546.
    [ PubMed Abstract ]
  • Berger VW. Different name, same problems. Contemp Clin Trials 2011;32(8)785.
    [ PubMed Abstract ]
  • Berger VW. Can objective endpoints be manipulated in unmasked trials? Stat Med 2011;30(30):3573-3574.
    [ PubMed Abstract ]
  • Berger VW. Commentary on Lin MF, Hsieh YJ, Fetzer S & Hsu MC (2011) A randomised controlled trial of the effect of music therapy and verbal relaxation on chemotherapy-induced anxiety. Journal of Clinical Nursing 20, 988-999. J Clin Nurs 2011;20(19-20):2980.
    [ PubMed Abstract ]
  • Berger VW. Intent-to-treat: further insight. Res Nurs Health 2011;34(1):4.
    [ PubMed Abstract ]
  • Berger VW. Minimization: not all it's cracked up to be. Clin Trials 2011;8:443, author reply 444.
    [ PubMed Abstract ]
  • Berger VW. Recognizing chronological bias for what it is. Clin Trials 2011;8(6):768; author reply 769.
    [ PubMed Abstract ]
  • Berger VW. Trials: the worst possible design (except for all the rest). The International Journal of Person Centered Medicine 2011;1(3):630-631.
  • Berger VW, Izmirlian G, Knoll D. Discussion of the paper of Ghosh, Taylor, and Sargent. Biometrics 2011 June 22.
    [ PubMed Abstract ]
  • Berger VW, Knoll D. A note on the evaluation of BoNTA trial quality. Inflammopharmacology 2011;19(5):243-244.
    [ PubMed Abstract ]
  • Berger VW, Knoll D. Levels of evidence: further insight on Gugiu and Gugiu. Eval Health Prof 2011;34(1):124-126; discussion 127-130.
    [ PubMed Abstract ]
  • Berger VW, Vali B. Intent-to-randomize corrections for missing data resulting from run-in selection bias in clinical trials for chronic conditions. J Biopharm Stat 2011;21(2):263-270.
    [ PubMed Abstract ]
  • Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu J-L, Prorok PC, Gohagan JK, Berg CD for the PLCO Project Team. Effect of screening on ovarian cancer mortality. the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. JAMA 2011;305(22):2295-2303.
    [ PubMed Abstract ]
  • Crawford ED, Grubb RL, Black A, Andriole GL, Chen MH, Izmirlian G, Berg CD, D'Amico AV. Comorbidity and mortality results from a randomized prostate cancer screening trial J Clin Oncol 2011;29(4):355-361.
    [ PubMed Abstract ]
  • Doubeni CA, Schootman M, Major JM, Torres Stone RA, Laiyemo AO, Park Y, Lian M, Messer L, Graubard BI, Sinha R, Hollenbeck AR, Schatzkin A. Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health 2011 Aug 18.
    [ PubMed Abstract ]
  • Driscoll WW, Pepper JW, Pierson LS, Pierson EA. Spontaneous gac mutants of Pseudomonas biological control strains: cheaters or mutualists? Applied and Environmental Microbiology 2011;77(20):7227-7235.
    [ PubMed Abstract ]
  • Fan YG, Jiang Y, Chang RS, Yao SX, Jin P, Wang W, He J, Zhou QH, Prorok P, Qiao YL, Hu P.Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China. Lung Cancer 2011;72(2):258-263.
    [ PubMed Abstract ]
  • Freedman LS, Midthune D, Carroll RJ, Tasevska N, Schatzkin A, Mares J, Tinker L, Potischman N, Kipnis V. Using regression calibration equations that combine self-reported intake and biomarker measures to obtain unbiased estimates and more powerful tests of dietary associations. Am J Epidemiol 2011;174(11):1238-1245.
    [ PubMed Abstract ]
  • Freedman LS, Schatzkin A, Midthune D, Kipnis V. Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst 2011;103(14):1086-1092.
    [ PubMed Abstract ]
  • Kramer BS, Berg CD, Aberle DR, Prorok PC. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen 2011;18(3):109-111.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiology 2011 Nov 21;Epub ahead of print.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Sanderson AK, Pinsky PF, Badurdeen DS, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Schatzkin A, Cross AJ. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc 2011;74(2):253-261.
    [ PubMed Abstract ]
  • Lian M, Schootman M, Doubeni CA, Park Y, Major JM, Torres Stone RA, Laiyemo AO, Hollenbeck AR, Graubard BI, Schatzkin A. Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP Diet and Health Study cohort. Am J Epidemiol 2011;174(7):828-838.
    [ PubMed Abstract ]
  • Marcus PM, Bergstralh EJ, Kramer BS, Fontana R. The Mayo Lung Project lung cancer mortality findings are unlikely to be biased by a volunteer effect. Eur J Epidemiol 2011;26(6):503-504.
    [ PubMed Abstract ]
  • Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD. The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. Contemp Clin Trials 2011;32(6):834-840.
    [ PubMed Abstract ]
  • Midthune D, Schatzkin A, Subar AF, Thompson FE, Freedman LS, Carroll RJ, Shumakovich MA, Kipnis V. Validating an FFQ for intake of episodically consumed foods: application to the National Institutes of Health-AARP Diet and Health Study. Public Health Nutr 2011;14(7):1212-1221.
    [ PubMed Abstract ]
  • Oh A, Dodd K, Ballard-Barbash R, Perna FM, Berrigan D. Language use and adherence to multiple cancer preventive health behaviors among Hispanics. J Immigr Minor Health 2011;13(5):849-859.
    [ PubMed Abstract ]
  • Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G, Pinsky PF, Prorok PC, Kramer BS, Miller AB, Gohagan JK, Berg CD, for the PLCO Project Team. Screening by chest radiograph and lung cancer mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial. JAMA 2011;306(17):1865-1873.
    [ PubMed Abstract ]
  • Pepper JW. Chapter 7: Somatic evolution of acquired drug resistance in cancer. Exit Disclaimer In Gioeli (ed). Targeted Therapies: Mechanisms of Resistance, Springer 2011;127-134.
  • Pignone M, Ransohoff DF. Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screening. Med Decis Making 2011;31(4):524-526.
    [ PubMed Abstract ]
  • Ransohoff DF, Yankaskas B, Gizlice Z, Gangarosa L. Recommendations for post-polypectomy surveillance in community practice. Dig Dis Sci 2011 Jun 23.
    [ PubMed Abstract ]
  • Rosenfeld S. Biomolecular self-defense and futility of high-specificity therapeutic targeting. Gene Regulation and Systems Biology 20115;89-104.
    [ PubMed Abstract ]
  • Rosenfeld S. Critical self-organized self-sustained oscillations in large regulatory networks: towards understanding the gene expression initiation. Gene Regulation and Systems Biology 2011;5:27-40.
    [ PubMed Abstract ]
  • Rosenfeld S. Mathematical descriptions of biochemical networks: stability, stochasticity, evolution. Prog Biophys Mol Biol 2011;106(2):400-409.
    [ PubMed Abstract ]
  • Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011 Jul;106(7):1340-1350.
    [ PubMed Abstract ]
  • Sprouffske K, Pepper JW, Maley CC. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res 2011;4(7):1135-1144.
    [ PubMed Abstract ]
  • Stovsky M, Ponsky L, Vourganti S, Stuhldreher P, Siroky MB, Kipnis V, Fedotoff O, Mikheeva L, Zaslavsky B, Chait A, Jones JS. Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples. Urology 2011;78(3):601-605.
    [ PubMed Abstract ]
  • Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg CD, Prorok PC. Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103(13):1058-1068.
    [ PubMed Abstract ]
  • Tasevska N, Cross AJ, Dodd KW, Ziegler RG, Caporaso NE, Sinha R. No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the Prostate, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2011;128(2):402-411.
    [ PubMed Abstract ]
  • Tasevska NA, Midthune D, Potischman N, Subar AF, Cross AJ, Bingham SA, Schatzkin A, Kipnis V. Use of the predictive sugars biomarker to evaluate self-reported total sugars intake in the Observing Protein and Energy Nutrition (OPEN) study. Cancer Epidemiol Biomarkers Prev 2011;20(3):490-500.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team (Fagerstrom RM, Izmirlian G, Marcus PM, Prorok PC). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team (Fagersrom RM, Izmirlian G, Marcus PM, Prorok P). The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253.
    [ PubMed Abstract ]
  • Verkaik-Kloosterman J, Dodd KW, Dekkers AL, van 't Veer P, Ocké MC. A three-part, mixed-effects model to estimate the habitual total vitamin D intake distribution from food and dietary supplements in Dutch young children. J Nutr 2011;141(11):2055-2063.
    [ PubMed Abstract ]
  • Wastney ME, Combs GF, Canfield WK, Taylor PR, Patterson KY, Hill AD, Moler JE, Patterson BH. A human model of selenium that integrates metabolism from selenite and selenomethionine. J Nutr 2011;141(4):708-717.
    [ PubMed Abstract ]
  • Zhang S, Krebs-Smith SM, Midthune D, Perez A, Buckman DW, Kipnis V, Freedman LS, Dodd KW, Carroll RJ. Fitting a bivariate measurement error model for episodically consumed dietary components. Int J Biostatistics 2011;7(1):1-32.
    [ PubMed Abstract ]
  • Zhang S, Midthune D, Guenther PM, Krebs-Smith SM, Kipnis V, Dodd KW, Buckman DW, Tooze JA, Freedman L, Carroll RJ. A new multivariate measurement error model with zero-inflated dietary data, and its application to dietary assessment. Ann Appl Stat 2011;5(2B):1456-1487.
    [ PubMed Abstract ]
  • Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) 2011;4(3):375-383.
    [ PubMed Abstract ]

2010

  • Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, Sempos CT, Picciano MF. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010;140(4):817-822.
    [ PubMed Abstract ]
  • Bailey RL, McDowell MA, Dodd KW, Gahche JJ, Dwyer JT, Picciano MF. Total folate and folic acid intakes from foods and dietary supplements of US children aged 1-13 y. Am J Clin Nutr 2010;92(2):353-358.
    [ PubMed Abstract ]
  • Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, Dodd KW, Sempos CT, Betz JM, Picciano MF. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. Am J Clin Nutr 2010;92(2):383-389.
    [ PubMed Abstract ]
  • Baker SG. Simple and flexible classification via Swirls and Ripples. BMC Bioinformatics (accepted in principle).
    [ PubMed Abstract ]
  • Baker SG, Cappuccio A, Potter JD. Research on early-stage carcinogenesis: are we approaching paradigm instability? J Clin Oncol 2010;28:3215-3218.
    [ PubMed Abstract ]
  • Baker SG, Darke AK, Pinsky P, Parnes HL, Kramer BS. Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial. Biostatistics 2010;11(3):413-418.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Evaluating Biomarkers For Cancer Screening Exit Disclaimer. Pharma IQ 31/08/2/2010, article ID: 3077.
  • Baker SG, Sargent DJ. Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk prediction. J Natl Cancer Inst 2010;102(23):1756-1759.
    [ PubMed Abstract ]
  • Belcher BR, Berrigan D, Dodd KW, Emken BA, Chou CP, Spuijt-Metz D. Physical activity in US youth: effect of race/ethnicity, age, gender, and weight status. Med Sci Sports Exerc 2010;42(12):2211-2221.
    [ PubMed Abstract ]
  • Berger VW. A Socratic dialogue. Journal of Applied Statistical Methods 2010;8(1):316-321.
  • Berger VW. Assessing the quality of randomization and allocation concealment. Osteoarthritis Cartilage 2010;18(10):1361; author reply 1362.
    [ PubMed Abstract ]
  • Berger VW. Assessing the quality of surgical trials: further insight. Ann Surg 2010 Dec 17;().
    [ PubMed Abstract ]
  • Berger VW. Exact permutation tests for correlated binomial variables: letter to the editor. Biometrical Journal 2010;52(3):436-437.
    [ PubMed Abstract ]
  • Berger VW. Making statistics boring again. Stat Med 2010;29(13);1458. [Letter to Editor]
    [ PubMed Abstract ]
  • Berger VW. Minimization, by its nature, precludes allocation concealment, and invites selection bias. Contemp Clin Trials 2010;31(5)406.
    [ PubMed Abstract ]
  • Berger VW. Permutation tests for stochastic ordering and ANOVA: theory and applications with R by BASSO, D., PESARIN, F., SALMASO, L., and SOLARI, A. Biometrics 2010;66(1):319-321.
  • Berger VW. Randomization, permuted blocks, masking, allocation concealment, and selection bias in the Tobacco Quit Line Study. Contemp Clin Trials 2010;31(3):201.
    [ PubMed Abstract ]
  • Berger VW. Testing for baseline balance: can we finally get it right? J Clin Epidemiol 2010;63(8)939-940; author reply 940-942.
    [ PubMed Abstract ]
  • Berger VW, Do AC. Allocation concealment continues to be misunderstood. J Clin Epidemiol 2010;63(4):468-469; author reply 469-470.
    [ PubMed Abstract ]
  • Berger VW, Grant WC, Vazquez LF. Sensitivity designs for preventing bias replication in randomized clinical trials. Stat Methods Med Res 2010;19(4):415-424.
    [ PubMed Abstract ]
  • Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG, Adenoma Prevention with Celecoxib (APC) Study Investigators (Corle D). Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev Res 2010;3(5);588-596.
    [ PubMed Abstract ]
  • Black A, Grubb R, Church T, Reding D, Izmirlian G, Hickey T, Mabie J, Riley T, Ragard L, Prorok P, Berg C, Crawford D, Andriole G. Comparison of risk estimates of factors associated with prostate cancer incidence and mortality between screened and control arms in the PLCO Trial. J Urol 2010;183(4):e53-e54.
  • Bobe G, Murphy G, Rogers CJ, Hance KW, Albert PS, Laiyemo AO, Sansbury LB, Lanza E, Schatzkin A, Cross AJ. Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 2010;19(6)1441-1452.
    [ PubMed Abstract ]
  • Crawford ED, Izmirlian G, Grubb RL, Kramer BS, Church TR, Black A, Riley TM, Hickey T, Ragard L, Prorok PC, Berg CD, Andriole GL. Factors influencing prostate cancer mortality in the PLCO Trial. J Urol 2010;183(4):e224-e225.
  • Cronin KA, Harlan LC, Dodd KW, Abrams JS, Ballard-Barbash R. Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. Cancer Invest 2010;28(9):963-968.
    [ PubMed Abstract ]
  • Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med 2010;152(8):505-512, W176-180.
    [ PubMed Abstract ]
  • Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol 2010;37(3):202-215.
    [ PubMed Abstract ]
  • Doria-Rose VP, Marcus PM, Miller AB, Bergstralh EJ, Mandel JS, Tockman MS, Prorok PC. Does the source of death information affect cancer screening efficacy results? a study of the use of mortality review versus death certificates in four randomized trials. Clin Trials 2010;7(1):69-77.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Klabunde CN, Young AC, Field TS, Fletcher RH. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med 2010;38(2):184-191.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Young AC, Klabunde CN, Reed G, Field TS, Fletcher RH. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med 2010;8(4):299-307.
    [ PubMed Abstract ]
  • Freedman LS, Guenther PM, Dodd KW, Krebs-Smith SM, Midthune D. The population distribution of ratios of usual intakes of dietary components that are consumed every day can be estimated from repeated 24-hour recalls. J Nutr 2010;140(1):111-116.
    [ PubMed Abstract ]
  • Freedman LS, Guenther PM, Krebs-Smith SM, Dodd KW, Midthune D. A population's distribution of Healthy Eating Index-2005 component scores can be estimated when more than one 24-hour recall is available. J Nutr 2010;140(8)1529-1534.
    [ PubMed Abstract ]
  • Freedman LS, Kipnis V, Schatzkin A, Tasevska N, Potischman N. Can we use biomarkers in combination with self-reports to strengthen the analysis of nutritional epidemiologic studies? Epidemiol Perspect Innov 2010;7(1)2. (doi: 10.1186/1742-5573-7-2)
    [ PubMed Abstract ]
  • Freedman LS, Tasevska N, Kipnis V, Schatzkin A, Mares J, Tinker L, Potischman N. Gains in statistical power from using a dietary biomarker in combination with self-reported intake to strengthen the analysis of a diet-disease association: An example from CAREDS. Am J Epidemiol 2010;172(7):836-842.
    [ PubMed Abstract ]
  • Grubb RL, Black A, Shaul S, Mabie J, Riley T, Kattan M, Izmirlian G, Vickers AJ, Bochner BH, Kibel AS, Prorok PC, Berg CD, Stephenson A, Andriole GL. Predicting the risk of bladder cancer and high-grade bladder cancer using patient clinical and demographic information from PLCO participation. J Urol 2010:183(4):e448-e449.
  • Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, Ragard LR, Commins J, Lynch DA, Andriole GL, Buys SS, Fouad MN, Fuhrman CR, Isaacs C, Yokochi LA, Riley TL, Pinsky PF, Gohagan JK, Berg CD for the PLCO Project Team. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst 2010;102:1-10.
    [ PubMed Abstract ]
  • Imperiale TF, Ransohoff DF. Understanding differences in the guidelines for colorectal cancer screening. Gastroenterology 2010;138(5):1642-1647.e1.
    [ PubMed Abstract ]
  • Klabunde CN, Marcus PM, Silvestri GA, Han PKJ, Richards TB, Yuan G, Marcus SE, Vernon SW. U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med 2010;39(5):411-420.
    [ PubMed Abstract ]
  • Krebs Smith SM, Guenther PM, Subar AF, Kirkpatrick SI, Dodd KW. Americans do not meet Federal dietary recommendations. J Nutr 2010;140(10):1832-1828.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, Crawford ED, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 2010;102(8):538-546.
    [ PubMed Abstract ]
  • Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010;21(1):163-170.
    [ PubMed Abstract ]
  • Leung K, Pinsky P, Laiyemo AO, Lanza E, Schatzkin A, Schoen RE. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study (PPT-CFS). Gastrointest Endosc 2010;71(1):111-117.
    [ PubMed Abstract ]
  • Marcus PM, Huang GC, Beck V, Miller MJ. The impact of a primetime cancer storyline: from individual knowledge and behavioral intentions to policy-level changes. J Cancer Educ 2010;25(4)484-489.
    [ PubMed Abstract ]
  • Meinhold CL, Dodd KW, Jiao L, Flood A, Shikany JM, Genkinger JM, Hayes RB, Stolzenberg-Solomon RZ. Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol 2010;171(11):1174-1182.
    [ PubMed Abstract ]
  • National Lung Screening Trial Research Team Writing Committee: Aberle DR, Adams A, Berg CD, Clapp J, Clingan K, Gareen IF, Lynch DA, Marcus PM, Pinsky P (Fagerstrom RF, Prorok PC). Baseline characteristics of participants in the National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-1779.
    [ PubMed Abstract ]
  • Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2010;91(2):449-455.
    [ PubMed Abstract ]
  • Pinsky PF, Black A, Kramer BS, Miller A, Prorok PC, Berg C. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2010;7(4)303-311.
    [ PubMed Abstract ]
  • Prorok PC, Marcus PM. Cancer screening trials: nuts and bolts. Semin Oncol 2010;37(3):216-223.
    [ PubMed Abstract ]
  • Ransohoff DF, Gourlay ML. Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol 2010;28(4):698-704.
    [ PubMed Abstract ]
  • Ransohoff DF, Khoury MJ. Personal genomics: information can be harmful. Eur J Clin Invest 2010;40(1):64-68.
    [ PubMed Abstract ]
  • Ransohoff DF. Can endoscopy protect against colorectal cancer? an RCT. Lancet 2010;375(9726):1582-1584.
    [ PubMed Abstract ]
  • Ransohoff DF. Proteomics research to discover markers: what can we learn from Netflix? Clin Chem 2010;56(2):172-176.
    [ PubMed Abstract ]
  • Reedy J, Wirfält E, Flood A, Mitrou PN, Krebs-Smith SM, Kipnis V, Midthune D, Leitzmann M, Hollenbeck A, Schatzkin A, Subar AF. Comparing 3 dietary pattern methods--cluster analysis, factor analysis, and index analysis--with colorectal cancer risk: the NIH-AARP Diet and Health Study. Am J Epidemiol 2010;171(4):479-487.
    [ PubMed Abstract ]
  • Regnier FE, Skates SJ, Mesri M, Rodriguez H, Tezak Z, Kondratovich MV, Alterman MA, Levin JD, Roscoe D, Reilly E, Callaghan J, Kelm K, Brown D, Philip R, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Ransohoff DF, Mansfield E, Anderson NL. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem 2010;56(2):165-171.
    [ PubMed Abstract ]
  • Rodriguez H, Tezak Z, Mesri M, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Philip R, Ransohoff DF, Skates SJ, Regnier FE, Anderson NL, Mansfield E, Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin Chem 2010;56(2):237-243.
    [ PubMed Abstract ]
  • Rosenfeld S. Do DNA microarrays tell the story of gene expression? Gene Regul Syst Bio 2010;4:61-73. (Early view)
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Reding DJ, Hayes RB, Church T, Yurgalevich S, Doria-Rose VP, Hickey T, Riley T, Berg CD. Utilization of surveillance colonoscopy in community practice. Gastroenterology 2010;138(1):73-81.
    [ PubMed Abstract ]
  • Sinha S, Mallick BK, Kipnis V, Carroll RJ. Semiparametric Bayesian analysis of nutritional epidemiology data in the presence of measurement error. Biometrics 2010;66:444-454.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team (Writing Committee: Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen, IF, Lynch DA, Marcus PM, Pinsky PF. Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-1779.
    [ PubMed Abstract ]
  • Tooze JA, Kipnis V, Buckman DW, Carroll RJ, Freedman LS, Guenther PM, Krebs-Smith SM, Subar AF, Dodd KW. A mixed-effects model approach for estimating the distribution of usual intake of nutrients: the NCI method. Stat Med 2010;29(27):2857-2868.
    [ PubMed Abstract ]
  • Zweig M, DeVoto E. Does the language fit the evidence?--Association versus causation. HealthNewsReview.org Feb 10, 2010.

2009

  • Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, et al. (Ransohoff DF). Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurement of proteins in plasma. Nat Biotechnology 2009;27(7):633-641.
    [ PubMed Abstract ]
  • Andriole GL, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, Crawford ED, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1309-1319.
    [ PubMed Abstract ]
  • Baker SG. Improving the biomarker pipeline to develop and evaluate cancer screening tests. J Natl Cancer Inst 2009;101(16):1116-1119.
    [ PubMed Abstract ]
  • Baker SG. Putting risk prediction in perspective: relative utility curves. J Natl Cancer Inst 2009;101:1538-1542.
    [ PubMed Abstract ]
  • Baker SG, Cook NR, Vickers A, Kramer BS. Using relative utility curves to evaluate risk prediction. J R Stat Soc A 2009;172:729-748.
    [ PubMed Abstract ]
  • Baker SG, Soto AM, Sonnenschein C, Cappuccio A, Potter JD, Kramer BS. Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer 2009;9:89.
    [ PubMed Abstract ]
  • Berger VW. Chewing gum and caries. J Am Dent Assoc 2009;140(6)638, 640; author reply 640.
  • Berger VW. Do methodological flaws invalidate a randomized trial of lifestyle modification programs in obese patients? Ann Intern Med 2009;151(1):70; author reply 70-1.
    [ PubMed Abstract ]
  • Berger VW. Do not test for baseline imbalances unless they are known to be present? Qual Life Res 2009;18(4):399.
    [ PubMed Abstract ]
  • Berger VW. Polyol-containing chewing gums: flawed evidence. Evid Based Dent 2009;10(2):36; author reply 36.
    [ PubMed Abstract ]
  • Berger VW. Right conclusion, wrong method. Eur J Contracept Reprod Health Care 2009;14(4):317-318; author reply 319-20.
    [ PubMed Abstract ]
  • Berger VW. The (lack of) quality in assessing the quality of transplantation trials. Transpl Int 2009;22(10);1029; author reply 1023.
    [ PubMed Abstract ]
  • Berger VW. Valid, adaptive, data-driven comparisons of binary end points. J Clin Epidemiol 2009;62(10):1112; author reply 1112-1113.
    [ PubMed Abstract ]
  • Berger VW, Alperson SY. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials 2009;4(2):79-88.
    [ PubMed Abstract ]
  • Berger VW, Do AC. Allocation concealment continues to be misunderstood. J Clin Epidemiol 2009; Dec 9;().
    [ PubMed Abstract ]
  • Berrigan D, Potischman N, Dodd KW, Hursting SD, Lavigne J, Barrett JC, Ballard-Barbash R. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Grow Horm IGF Res 2009;19(2):146-155.
    [ PubMed Abstract ]
  • Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET, Adenoma Prevention with Celecoxib Study Investigators (Corle D). Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila Pa) 2009;2(4):310-321.
    [ PubMed Abstract ]
  • Colón-Ramos U, Thompson FE, Yaroch AL, Moser RP, McNeel TS, Dodd KW, Atienza AA, Sugerman SB, Nebeling L. Differences in Fruit and Vegetable Intake among Hispanic Subgroups in California: results from the 2005 California Health Interview Survey. J Am Diet Assoc 2009;109(11):1878-1885.
    [ PubMed Abstract ]
  • Combs GF, Midthune DN, Patterson KY, Canfield WK, Hill AD, Levander OA, Taylor PR, Moler JE, Patterson BH. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 2009;89:1808-1814.
    [ PubMed Abstract ]
  • Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu J-L, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE. Cumulative incidence of false-positive results in repeated multimodal cancer screening. Annals of Family Medicine 2009;7(3):212-222.
    [ PubMed Abstract ]
  • Doria-Rose VP, Marcus PM. Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. Lung Cancer 2009;63(2):295-300.
    [ PubMed Abstract ]
  • Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009;115(21):5007-5017.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev 2009;18(8):2170-2175.
    [ PubMed Abstract ]
  • Durkalski VL, Berger VW. Re-formulating non-inferiority trials as superiority trials: the case of binary outcomes. Biom J 2009;51(1):185-192.
    [ PubMed Abstract ]
  • Fan Y-G, Hu P, Jiang Y, Chang R-S, Yao S-X, Wang W, He J, Prorok P, Qiao L. Association between sputum atypia and lung cancer risk in an occupational cohort in Yunnan, China. Chest 2009;135(3):778-785.
    [ PubMed Abstract ]
  • Gierada DS, Garg K, Nath H, Strollo DC, Fagerstrom RM, Ford MB. CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials. AJR Am J Roentgenol 2009;193(2):419-424.
    [ PubMed Abstract ]
  • Gren LH, Broski KG, Childs JC, Cordes JE, Engelhard DA, Gahagan BA, Gamito EJ, Gardner VC, Geisser MS, Higgins DM, Jenkins VL, Lamerato L, Lappe KA, Lowery H, McGuire CJ, Miedzinski MM, Ogden SL, Tenorio SL, Watt GD, Wohlers BL, Marcus PM. Recruitment methods employed in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Clinical Trials 2009;6:52-59.
    [ PubMed Abstract ]
  • Grubb RL, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2009;18(3):748-751.
    [ PubMed Abstract ]
  • Hewitt CE, Torgerson DJ, Berger VW. Potential for technical errors and subverted allocation can be reduced if certain guidelines are followed: examples from a web-based survey. J Clin Epidemiol 2009;62(3):261-269.
    [ PubMed Abstract ]
  • Imperiale TF, Glowinski EA, Juliar BE, Azzouz F, Ransohoff DF. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc 2009;69(7):1288-1295.
    [ PubMed Abstract ]
  • Izmirlian G. Prostate-cancer screening. N Engl J Med 2009;361(2):204; author reply 205-206.
    [ PubMed Abstract ]
  • Kafadar K, Prorok PC. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected. Stat Med 2009;28(16):2116-2146.
    [ PubMed Abstract ]
  • Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J, The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009;11(8):559-567.
    [ PubMed Abstract ]
  • Kipnis V, Midthune D, Buckman DW, Dodd KW, Guenther PM, Krebs-Smith SM, Subar AF, Tooze JA, Carroll RJ, Freedman LS. Modeling data with excess zeros and measurement error: application to evaluating relationships between episodically consumed foods and health outcomes. Biometrics 2009;65(4)1003-1010.
    [ PubMed Abstract ]
  • Lacey JV, Kreimer AR, Buys SS, Marcus PM, Chang SC, Leitzmann MF, Hoover RN, Prorok PC, Berg CD, Hartge P, PLCO Cancer Screening Trial Project Team. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial cohort. BMC Cancer 2009 Mar 17.
    [ PubMed Abstract ]
  • Laiyemo AO, Jack M, Dawkins FW, Smoot DT. Upper gastrointestinal bleeding from metastatic testicular cancer. J Natl Med Assoc 2009;101(8):808-809.
    [ PubMed Abstract ]
  • Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ.Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study. Cancer Epidemiol 2009;33(5):368-373.
    [ PubMed Abstract ]
  • Laiyemo AO, Murphy G, Sansbury LB, Wang Z, Albert PS, Marcus PM, Schoen RE, Cross AJ, Schatzkin A, Lanza E. Hyperplastic polyps and the risk of adenoma recurrence in the Polyp Prevention Trial. Clin Gastroenterol Hepatol 2009;7(2):192-197.
    [ PubMed Abstract ]
  • Laiyemo AO, Pinsky PF, Marcus PM, Lanza E, Cross AJ, Schatzkin A, Schoen RE. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol 2009;7(5):562-567; quiz 497.
    [ PubMed Abstract ]
  • Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc 2009;70(6):1182-1199.
    [ PubMed Abstract ]
  • Meissner HI, Yabroff KR, Dodd KW, Leader AE, Ballard-Barbash R, Berrigan D. Are patterns of health behavior associated with cancer screening? Am J Health Promot 2009;23(3):168-175.
    [ PubMed Abstract ]
  • Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E. Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial. Int J Cancer 2009;124(9):2148-2151.
    [ PubMed Abstract ]
  • Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A. Hormone therapy in relation to survival from large bowel cancer. Cancer Causes Control 2009;20(4):409-416.
    [ PubMed Abstract ]
  • Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, Kessel B, Johnson CC, Weissfeld L, Isaacs C, Andriole GL, Ogden S, Ragard LR, Buys SS. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 2009;113(4):775-782.
    [ PubMed Abstract ]
  • Pinsky PF, Schoen RE, Weissfeld JL, Church T, Yokochi LA, Doria-Rose VP, Prorok P. The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 2009;7(1):86-92.
    [ PubMed Abstract ]
  • Ransohoff DF. Promises and limitations of biomarkers. Recent Results Cancer Res 2009;181:55-59.
    [ PubMed Abstract ]
  • Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med 2009;150(1):50-52.
    [ PubMed Abstract ]
  • Rosenfeld S. Characteristics of transcriptional activity in nonlinear dynamics of genetic regulatory networks. Gene Regulation and Systems Biology 2009;3:159-179.
    [ PubMed Abstract ]
  • Rosenfeld S.Origins of stochasticity and burstiness in high-dimensional biochemical networks . EURASIP J Bioinform Syst Biol 2009; Article ID 362309.
    (EURASIP J Bioinform Syst Biol. 2009; 2009: 362309. Published online 2008 October 16. doi: 10.1155/2009/362309)
    [ PubMed Abstract ]
  • Rosenfeld S. Patterns of stochastic behavior in dynamically unstable high-dimensional biochemical networks. Gene Regulations and Systems Biology 2009;(3):1-10.
    [ PubMed Abstract ]
  • Sansbury LB, Wanke K, Albert PS, Kahle L, Schatzkin A, Lanza E, Polyp Prevention Trial Study Group (Corle D). The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence. Am J Epidemiol 2009;170(5):576-584.
    [ PubMed Abstract ]
  • Schatzkin A, Subar AF, Moore S, Park Y, Potischman N, Thompson FE, Leitzmann M, Hollenbeck A, Morrissey KG, Kipnis V. Observational epidemiologic studies of nutrition and cancer: the next generation (with better observation). Cancer Epidemiol Biomarkers Prev 2009;18(4):1026-1032.
    [ PubMed Abstract ]
  • Tamers SL, Agurs-Collins T, Dodd KW, Nebeling L. US and France adult fruit and vegetable consumption patterns: an international comparison. Eur J Clin Nutr 2009;63:11-17.
    [ PubMed Abstract ]
  • Tammemagi M, Freedman MT, Pinsky PF, Oken MM, Hu P, Riley TL, Ragard LR, Berg CD, Prorok PC. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol 2009;4(6):710-721.
    [ PubMed Abstract ]
  • Tasevska N, Sinha R, Kipnis V, Subar AF, Leitzmann MF, Hollenbeck AR, Caporaso NE, Schatzkin A, Cross AJ. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 2009;89(6):1884-1894.
    [ PubMed Abstract ]
  • Thompson FE, McNeel TS, Dowling EC, Midthune D, Morrissette M, Zeruto CA. Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc 2009;109(8):1376-1383.
    [ PubMed Abstract ]
  • Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, Ransohoff DF. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009;150(12):849-857, W152.
    [ PubMed Abstract ]
  • Weiss NS, Doria-Rose VP. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 2009;150(11):817-818; author reply 819-820.
    [ PubMed Abstract ]
  • Wirfält E, Midthune D, Reedy J, Mitrou P, Flood A, Subar AF, Leitzmann M, Mouw T, Hollenbeck AR, Schatzkin A, Kipnis V. Associations between food patterns defined by cluster analysis and colorectal cancer incidence in the NIH-AARP diet and health study. Eur J Clin Nutr 2009;63(6):707-717.
    [ PubMed Abstract ]
  • Xu J-L, Prorok PC. On testing independence of repeated screening tests (letter). J Med Screen 2009;16(1):50; author reply 51.
    [ PubMed Abstract ]

2008

  • Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow WH. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 2008;168(3):268-277.
    [ PubMed Abstract ]
  • Baker SG. Two simple approaches for validating a binary surrogate endpoint using data from multiple trials. Stat Methods Med Res 2008;17(5):505-514.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests. J Med Screen 2008;15:18-22.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Randomized trials for the real world: making as few and as reasonable assumptions as possible. Stat Methods Med Res 2008;17(3):243-252.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Surrogate endpoints. Encyclopedia of Cancer. New York: Springer-Verlag, 2008 10.1007/978-3-540-47648-1_5602.
  • Baker SG, Kramer BS. Using microarrays to study the microenvironment in tumor biology: the crucial role of statistics. Semin Cancer Biol 2008;18(5):305-310.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Prorok PC. Early reporting for cancer screening trials. J Med Screen 2008;15(3):122-129.
    [ PubMed Abstract ]
  • Berger VW. Controversies in clinical trials. Stat Methods Med Res 2008;17(3):229-230.
    [ PubMed Abstract ]
  • Berger VW. Regarding paper "A note on P-values for two-sided tests". Biom J 2008;50(6):1093-1095; author reply 1096-1097.
    [ PubMed Abstract ]
  • Berger VW, Matthews JR, Grosch EN. On improving research methodology in clinical trials. Stat Methods Med Res 2008;17(3):231-242.
    [ PubMed Abstract ]
  • Berger VW, Zhang S, Zhou YY. Comment on Fygenson. Statistica Sinica 2008;18:55-58.
  • Black WC, Aberle DA, Berg CD on behalf of the Executive Committee of the National Lung Screening Trial (Prorok PC, Fagerstrom RM, Marcus PM). In response to: Will the National Lung Screening Trial be able to demonstrate a mortality reduction. Radiology 2008;246:653-654.
    [ PubMed Abstract ]
  • Doria-Rose VP, Marcus PM. Lung cancer screening by sputum cytology and chest x-ray: Results from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Am J Epidemiol 2008;167:S108.
    [ PubMed Abstract ]
  • Doria-Rose VP, Miller AB, Prorok PC, Marcus PM. Do death certificates provide an adequate source of cause of death information in randomized controlled trials of cancer screening? Am J Epidemiol 2008;167:S108.
    [ PubMed Abstract ]
  • Flood A, Rastogi T, Wirfält E, Mitrou PN, Reedy J, Subar AF, Kipnis V, Mouw T, Hollenbeck AR, Leitzmann M, Schatzkin A. Dietary patterns as identified by factor analysis and colorectal cancer among middle-aged Americans. Am J Clin Nutr 2008;88(1):176-184.
    [ PubMed Abstract ]
  • Freedman LS, Kipnis V, Schatzkin A, Potischman N. Methods of epidemiology: evaluating the fat-breast cancer hypothesis--comparing dietary instruments and other developments. Cancer J 2008;14(2):69-74.
    [ PubMed Abstract ]
  • Freedman LS, Midthune D, Carroll RJ, Kipnis V. A comparison of regression calibration, moment reconstruction and imputation for adjusting for covariate measurement error in regression. Stat Med 2008;27(25):5195-5216.
    [ PubMed Abstract ]
  • Gierada DS, Pilgram TK, Ford M, Fagerstrom RM, Church TR, Nath H, Garg K, Strollo DC. Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology 2008;246(1):265-272.
    [ PubMed Abstract ]
  • Greene GW, Resnicow K, Thompson FE, Peterson KE, Hurley TG, Hebert JR, Toobert DJ, Williams GC, Elliot DL, Goldman Sher T, Domas A, Midthune D, Stacewicz-Sapuntzakis M, Yaroch AL, Nebeling L. Correspondence of the NCI Fruit and Vegetable Screener to repeat 24-H recalls and serum carotenoids in behavioral intervention trials. J Nutr 2008;138(1):200S-204S.
    [ PubMed Abstract ]
  • Grubb RL, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int 2008;102(11):1524-1530.
    [ PubMed Abstract ]
  • Hebert JR, Hurley TG, Peterson KE, Resnicow K, Thompson FE, Yaroch AL, Ehlers M, Midthune D, Williams GC, Greene GW, Nebeling L. Social desirability trait influences on self-reported dietary measures among diverse participants in a multicenter multiple risk factor trial. J Nutr 2008;138(1):226S-234S.
    [ PubMed Abstract ]
  • Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359(12):1218-1224.
    [ PubMed Abstract ]
  • Izmirlian G. Reply to "Open Source Mathematical Software". Notices of the American Mathematical Society 2008;55(3):342.
  • Johnson CC, Kessel B, Riley TL, Ragard LR, Williams CR, Xu JL, Buys SS. The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. Gynecol Oncol 2008;110(3):383-389.
    [ PubMed Abstract ]
  • Kipnis V, Freedman LS. Impact of exposure measurement error in nutritional epidemiology. J Natl Cancer Inst 2008;100(23):1658-1659.
    [ PubMed Abstract ]
  • Kipnis V, Midthune D, Buckman DW, Dodd KW, Guenther PM, Krebs-Smith SM, Subar AF, Tooze JA, Carroll RJ, Freedman FS. Modeling data with excess zeros and measurement error: Application to evaluating relationships between episodically consumed foods and health outcomes. Biometrics 2009;65(4):1003-1010.
    [ PubMed Abstract ]
  • Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008;68(4 Suppl):S3-47.
    [ PubMed Abstract ]
  • Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z, Cross AJ, Marcus PM, Caan B, Marshall JR, Lance P, Paskett ED, Weissfeld J, Slattery ML, Burt R, Iber F, Shike M, Kikendal JW, Lanza E, Schatzkin A. Postpolypectomy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 2008;148:419-426.
    [ PubMed Abstract ]
  • Laiyemo AO, Smoot DT. Metastatic gastric stump cancer occurring six years after a partial gastrectomy for gastric ulcer. J Natl Med Assoc 2008;100(6):737-739.
    [ PubMed Abstract ]
  • Lamerato LE, Marcus PM, Jacobsen G, Johnson CJ. Recruitment in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: The Henry Ford Health System Experience. Cancer Epidemiol Biomarkers Prev 2008;17:827-833.
    [ PubMed Abstract ]
  • Midthune D, Kipnis V, Freedman LS, Carroll RJ. Binary regression in truncated samples, with application to comparing dietary instruments in a large prospective study. Biometrics 2008;64:289-298.
    [ PubMed Abstract ]
  • Murphy G, Sansbury LB, Cross AJ, Stolzenberg-Solomon R, Laiyemo A, Albert PS, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control 2008;19(7):751-758.
    [ PubMed Abstract ]
  • Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst 2008;100:291-298.
    [ PubMed Abstract ]
  • Ransohoff DF. The process to discover and develop biomarkers for cancer: a work in progress. J Natl Cancer Inst 2008;100(20):1419-1420.
    [ PubMed Abstract ]
  • Ransohoff DF, Martin C, Wiggins WS, Hitt BA, Keku TO, Galanko JA, Sandler RS. Assessment of serum proteomics to detect large colon adenomas. Cancer Epidemiol Biomarkers Prev 2008;17(8):2188-2193.
    [ PubMed Abstract ]
  • Reedy J, Mitrou PN, Krebs-Smith SM, Wirfält E, Flood A, Kipnis V, Leitzmann M, Mouw T, Hollenbeck A, Schatzkin A, Subar AF. Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 2008;168(1):38-48.
    [ PubMed Abstract ]
  • Rosenfeld S. Approximate bivariate gamma generator with prespecified correlation and different marginal shapes. ACM Trans Model Comput Simul 2008;18(4:Article 16):16:1-16:20.
  • Rosenfeld S. Why do high-dimensional networks seem to be stable?-A reflection on stochasticity of dynamically unstable nonlinear systems. In Gauges R, Kummer U, Pahle J, Willy P (eds). Fifth Workshop on Computation of Biochemical Pathways and Genetic Networks. Heidelberg: University of Heidelberg, 2008:101-112.
  • Rosenfeld S, Kapetanovic I. Systems biology and cancer prevention: all options on the table. Gene Regulations and Systems Biology 2008;2:307-319.
    [ PubMed Abstract ]
  • Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev 2008;17(4):799-804.
    [ PubMed Abstract ]
  • Stewart J, Ware J, Boysen C, Gulati S, Zhou Z, Rosenfeld S, Kopelovich L, Kennedy AR. Effects of selenomethionine on the gene expression profile of cloned human prostate cancer cells representing a phenotypic continuum of cancer progression. Nutr Cancer 2008;60(6):826-836.
    [ PubMed Abstract ]
  • Thiébaut AC, Kipnis V, Schatzkin A, Freedman LS. The role of dietary measurement error in investigating the hypothesized link between dietary fat intake and breast cancer--a story with twists and turns. Cancer Invest 2008;26(1):68-73.
    [ PubMed Abstract ]
  • Thompson FE, Kipnis V, Midthune D, Freedman LS, Carroll RJ, Subar AF, Brown CC, Butcher MS, Mouw T, Leitzmann M, Schatzkin A. Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr 2008;11(2):183-195.
    [ PubMed Abstract ]
  • Thompson FE, Midthune D, Williams GC, Yaroch AL, Hurley TG, Resnicow K, Hebert JR, Toobert DJ, Greene GW, Peterson K, Nebeling L. Evaluation of a short dietary assessment instrument for percentage energy from fat in an intervention study. J Nutr 2008;138(1):193S-199S.
    [ PubMed Abstract ]
  • Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Prevalence of physical activity among youth and adults in the United States as measured by accelerometer in the National Health and Nutrition Examination Survey (NHANES) 2003-2004. Med Sci Sports Exercise 2008;40:181-188.
    [ PubMed Abstract ]
  • Williams GC, Hurley TG, Thompson FE, Midthune D, Yaroch AL, Resnicow K, Toobert DJ, Greene GW, Peterson K, Nebeling L, Patrick H, Hardin JW, Hebert JR. Performance of a short percentage energy from fat tool in measuring change in dietary intervention studies. J Nutr 2008;138(1):212S-217S.
    [ PubMed Abstract ]
  • Yanetz R, Kipnis V, Carroll RJ, Dodd KW, Subar AF, Schatzkin A, Freedman LS. Using biomarker data to adjust estimates of the distribution of usual intakes for misreporting: application to energy intake in the US population. J Am Diet Assoc 2008;108(3):455-464; discussion 464.
    [ PubMed Abstract ]
  • Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF, Brown ML. Implications of new colorectal cancer screening technologies for primary care practice. Med Care 2008;46(9 Suppl 1):S138-146.
    [ PubMed Abstract ]

2007

  • Adams KF, Leitzmann MF, Albanes D, Kipnis V, Mouw T, Hollenbeck A, Schatzkin A. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol 2007;166(1):36-45.
    [ PubMed Abstract ]
  • Ahn J, Schatzkin A, Lacey JV Jr, Albanes D, Ballard-Barbash R, Adams KF, Kipnis V, Mouw T, Hollenbeck AR, Leitzmann MF. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007;167(19):2091-2102.
    [ PubMed Abstract ]
  • Baker SG. Letter to the editor on causal inference for vaccines. J Am Stat Assoc 2007;102:394.
  • Baker SG. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2007;99(6)487-489.
    [ PubMed Abstract ]
  • Baker SG, Frangakis C, Lindeman KS. Estimating efficacy in a proposed randomized trial with initial and later noncompliance. J R Statist Soc C 2007;56:211-221.
  • Baker SG, Kaprio J. Genes, cancer, and twins--the statistics behind the headlines. Chance 2007;20,:59-62.
  • Baker SG, Kramer BS. Paradoxes in carcinogenesis: new opportunities for research directions. BMC Cancer 2007;7:151.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Peirce, Youden, and Receiver Operating Characteristic Curves. The American Statistician 2007; November:343-346.
  • Berg CD, Aberle DR, for the National Lung Screening Trial Executive Committee (Prorok PC, Fagerstrom RM, Marcus PM). In response to: The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. New Eng J Med 2007;356:743-744.
  • Berg CD, Aberle DR, for the National Lung Screening Trial Executive Committee (Prorok PC, Fagerstrom RM, Marcus PM). In response to: Computed tomography screening and lung cancer outcomes. Journal of the American Medical Association 2007;298:513-514.
  • Berger VW. Drawbacks to non-integer scoring for ordered categorical data. Biometrics 2007;63(1):298-299.
    [ PubMed Abstract ]
  • Berger VW, Gee E. On confusing prima facie validity with true validity. Br J Dermtol 2007;157(2):425-426.
    [ PubMed Abstract ]
  • Berrigan D, Potishman N, Dodd K, Micar M, McQuillan, Lavinge J, Barrett JC, Ballard-Barbash R. Serum levels of insulin-like growth factor 1 (IGF-1) and IGF-1 binding protein-3 (IGFBP-3): quality control for studies of stored serum. Cancer Epidemiol Biomarkers Prev 2007;16:1017-1022.
    [ PubMed Abstract ]
  • Black WC, Aberle DR, Berg CD, on behalf of the Executive Committee of the National Lung Screening Trial (Prorok PC, Fagerstrom RM, Marcus PM). Large field trial for lung cancer screening: putting the wrong cart before the horse? In response to: Gur D. Lung cancer screening: radiology's opportunity here and now. Radiology 2007;243:314-316.
    [ PubMed Abstract ]
  • Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, Hollenbeck A, Schatzkin A, Leitzmann MF. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 2007;18(5):493-503.
    [ PubMed Abstract ]
  • Davidov O, Hu P. Early detection programs in medical care. In Ruggeri F, Kenett R, Faltin F, editors. Encyclopedia of Statistics in Quality and Reliability. Chichester (U.K.): John Wiley & Sons, 2007:583-589.
  • Doria-Rose VP, Marcus PM, Church TR, Mongin S, Prorok PC. The evaluation of self-selection bias in observational studies of cancer screening using data from randomized controlled trials. Am J Epidemiol 2007;165:S33.
  • Doria-Rose VP, Marcus PM. Sensitivity and specificity of death certificates in assigning lung cancer as the cause of death in the Mayo Lung Project. Am J Epidemiol 2007;165:S32.
    [ PubMed Abstract ]
  • Fletcher RH, Ransohoff DF, Imperiale TF. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2007;109(9):1925-1926; author reply 1926.
    [ PubMed Abstract ]
  • Freedman LS, Schatzkin A, Thiébaut AC, Potischman N, Subar AF, Thompson FE, Kipnis V. Abandon neither the food frequency questionnaire nor the dietary fat-breast cancer hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16(6):1321-1322.
    [ PubMed Abstract ]
  • Howerton MW, Bell BS, Dodd KW, Berrigan D, Stolzenberg-Solomon R, Nebeling L. School-based nutrition programs produced a moderate increase in fruit and vegetable consumption: meta and pooling analyses from 7 studies. J Nutr Educ Behav 2007;39(4):186-196.
    [ PubMed Abstract ]
  • Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF, Winawer SJ. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med 2007;22(8):1195-1205.
    [ PubMed Abstract ]
  • Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, Kipnis V, Mouw T, Carroll L, Schatzkin A, Hartge P. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007;166(6):697-708.
    [ PubMed Abstract ]
  • Lissner L, Troiano RP, Midthune D, Heitmann BL, Kipnis V, Subar AF, Potischman N. OPEN about obesity: recovery biomarkers, dietary reporting errors and BMI. Int J Obes (Lond) 2007;31(6):956-961.
    [ PubMed Abstract ]
  • Marcus PM. MRI evaluation of breast cancer. N Engl J Med 2007;357(2):192; author reply 193.
    [ PubMed Abstract ]
  • Marcus PM, Harris A, Offord K. In response to: Morabia A, Markowitz S's response to: Extended lung cancer incidence follow-up in the Mayo Lung Project: additional support for overdiagnosis. J Natl Cancer Inst 2007;99:899.
  • Mitrou PN, Kipnis V, Thiébaut AC, Reedy J, Subar AF, Wirfält E, Flood A, Mouw T, Hollenbeck AR, Leitzmann MF, Schatzkin A. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 2007;167(22):2461-2468.
    [ PubMed Abstract ]
  • Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter, JD. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007;67(15):7534-7539.
    [ PubMed Abstract ]
  • Pandya K, Hu P, Osborne CK, Falkson G, Tormey DC. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer. an Eastern Cooperative Oncology Group Intergroup Study (E3185). Am J Clin Oncol 2007;30(2):113-125.
    [ PubMed Abstract ]
  • Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 2007;166(11):1270-1279.
    [ PubMed Abstract ]
  • Park Y, Subar AF, Kipnis V, Thompson FE, Mouw T, Hollenbeck A, Leitzmann MF, Schatzkin A. Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol 2007;166(2):170-180.
    [ PubMed Abstract ]
  • Patterson BH, Wastney ME, Combs GF. Calculation of the amounts of organic and inorganic selenium in the human diet from kinetic studies. In Hanigan MD, Novotny JA, Marstellar CL (eds). Mathematical Modeling in Nutrition and the Health Sciences. Blacksburg, VA:Virginia Institute of Technology 2007;213-222.
  • Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P, Gelmann E, Schoen RE, Buys S, Hayes RB, Berg CD. Evidence of a healthy volunteer effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 2007;165(8):874-881.
    [ PubMed Abstract ]
  • Ransohoff DF. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design. J Clin Epidemiol 2007;60(12):1205-1219.
    [ PubMed Abstract ]
  • Ransohoff DF. What is the role of iFOBT in screening for colorectal cancer? Gut 2007;56(10):1343-1344.
    [ PubMed Abstract ]
  • Rosenfeld S. Detection of differentially expressed genes in small sets of cDNA microarrays. Journal of Data Science 2007;5(3):451-469.
  • Rosenfeld S. Stochastic cooperativity in non-linear dynamics of genetic regulatory networks. Mathematical Biosciences 2007;210:121-142.
    [ PubMed Abstract ]
  • Schatzkin A, Mouw T, Park Y, Subar AF, Kipnis V, Hollenbeck A, Leitzmann MF, Thompson FE. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr 2007;85(5):1353-1360.
    [ PubMed Abstract ]
  • Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev 2007;16(10):2118-2127.
    [ PubMed Abstract ]
  • Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, Schairer C, Thompson FE, Kipnis V, Hollenbeck A, Schatzkin A, Sinha R. Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 2007;16(12):2664-2675.
    [ PubMed Abstract ]
  • Tammemagi CM, Freedman MT, Church TR, Oken MM, Hocking WG, Kvale PA, Hu P, Riley TL, Ragard LR, Prorok PC, Berg CD. Factors associated with human small aggressive non small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2007;16(10):2082-2089.
    [ PubMed Abstract ]
  • Thiébaut AC, Freedman LS, Carroll RJ, Kipnis V. Is it necessary to correct for measurement error in nutritional epidemiology? Ann Intern Med 2007;146(1):65-67.
    [ PubMed Abstract ]
  • Thiébaut AC, Kipnis V. Dietary fat underreporting and risk estimation. Public Health Nutr 2007;10(2):212-214.
    [ PubMed Abstract ]
  • Thiébaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007;99(6):451-462.
    [ PubMed Abstract ]
  • Thompson FE, Midthune D, Subar AF, Kipnis V, Kahle LL, Schatzkin A. Development and evaluation of a short instrument to estimate usual dietary intake of percentage energy from fat. J Am Diet Assoc 2007;107(5):760-767.
    [ PubMed Abstract ]
  • Tooze JA, Schoeller DA, Subar AF, Kipnis V, Schatzkin A, Troiano RP. Total daily energy expenditure among middle-aged men and women: the OPEN Study. Am J Clin Nutr 2007;86(2):382-387.
    [ PubMed Abstract ]
  • Vogt TM, Ziegler RG, Patterson BH, Graubard BI. Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2007;166(3):280-288.
    [ PubMed Abstract ]
  • Welch HG, Woloshin S, Schwartz LM, Gordis L, Gøtzsche PC, Harris R, Kramer BS, Ransohoff DF. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 2007;167(21):2289-2295.
    [ PubMed Abstract ]
  • Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007;109(4):675-684
    [ PubMed Abstract ]
  • Xu J-L. On estimating a survival function under the generalized proportional hazards model. Journal of Statistical Planning & Inference 2007;137:1161-1172.

2006

  • Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med 2006;355(8):763-778.
    [ PubMed Abstract ]
  • Baker SG. A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint. Biostatistics 2006 Jan;7(1)58-70.
    [ PubMed Abstract ]
  • Baker SG. Surrogate endpoints: wishful thinking or reality? (Editorial). J Natl Cancer Inst 2006;98(8):502-503.
    [ PubMed Abstract ]
  • Baker SG. Screening and breast cancer. Letter to the editor. N Engl J Med 2006;354:767-768.
  • Baker SG, Fitzmaurice GM, Freedman LS, Kramer BS. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates. Biostatistics 2006 Jan;7(1)29-40.
    [ PubMed Abstract ]
  • Baker SG, Kaprio J. Common susceptibility genes for cancer: search for the end of the rainbow. Br Med J 2006;332:1150-1152.
    [ PubMed Abstract ]
  • Baker SG, Kaprio J. Response to letter from Professor Lubinski regarding "Common susceptibility genes for cancer: search for the end of the rainbow". Br Med J 2006, Rapid Response
    [ PubMed Abstract ]
  • Baker SG, Kaprio J. Response to letter by Professor Luzzatto regarding "Common susceptibility genes for cancer: search for the end of the rainbow". Br Med J 2006;Rapid Response.
  • Baker SG, Kramer BS. Identifying genes that contribute most to good classification in microarrays. BMC Bioinformatics 2006;7:407.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Why biotechnologists should care about biostatistics. Asia-Pacific Biotech News 2006(30 November);10(22):1275-1278.
  • Baker SG, Kramer BS, Lindeman KS. The paired availability design: if you can't randomize, perhaps this applies. Chance 2006;19:57-60.
  • Baker SG, Kramer BS, McIntosh M, Patterson BH, Shyr Y, Skates S. Evaluating markers for the early detection of cancer: overview of study designs and methods of analysis. Clinical Trials 2006;3:43-56.
    [ PubMed Abstract ]
  • Berger VW. A review of methods for ensuring the comparability of comparison groups in randomized clinical trials. Rev Recent Clin Trials 2006;1(1):81-86.
    [ PubMed Abstract ]
  • Berger VW. Can pain be quantified numerically? J Rheumatol 2006;33(11):2364-2365.
    [ PubMed Abstract ]
  • Berger VW. Critical appraisal of individual trials? Am J Gastroenterol 2006;101(5):1156-1157.
    [ PubMed Abstract ]
  • Berger VW. Do not use blocked randomization. Headache 2006;46(2)343-345.
    [ PubMed Abstract ]
  • Berger VW. Is the Jadad score the proper evaluation of trials? J Rheumatol 2006;33(8):1710-1712.
    [ PubMed Abstract ]
  • Berger VW. Misguided precedent is not a reason to use permuted blocks. Headache 2006;46(7):1210-1212.
    [ PubMed Abstract ]
  • Berger VW. Missing data should be more heartily penalized. J Clin Epidemiol 2006;59:759-760.
  • Berger VW. Response to Klassen et al: Missing data should be more heartily penalized. J Clin Epidemiol 2006;59(7):759-760.
    [ PubMed Abstract ]
  • Berger VW. Varying the block size does not conceal the allocation. Journal of Critical Care 2006;21(2):229-230.
    [ PubMed Abstract ]
  • Berger VW, Matthews Jr. What does biostatistics mean to us? Mens Sana Monographs III 2006;6(Ivm 1-4):89-103.
    [ PubMed Abstract ]
  • Berger VW, Stefanesco C. The analysis of stratified 2x2 contingency tables. Biom J 2006;48(6):992-1007.
    [ PubMed Abstract ]
  • Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET; APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006;355(9):873-884.
    [ PubMed Abstract ]
  • Carroll RJ, Midthune D, Freedman LS, Kipnis V. Seemingly unrelated measurement error models, with application to nutritional epidemiology. Biometrics 2006;62(1):75-84.
    [ PubMed Abstract ]
  • Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK. Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial. J Urol 2006;175(4):1286-1290.
    [ PubMed Abstract ]
  • Dodd KW, Guenther PM, Freedman LS, Subar AF, Kipnis V, Midthune D, Tooze JA, Krebs-Smith SM. Statistical methods for estimating usual intake of nutrients and foods: a review of the theory. J Am Diet Assoc 2006;106(10):1640-1650.
    [ PubMed Abstract ]
  • Dores GM, Chang S, Berger VW, Perkins SN, Hursting SD, Weed DL. Evaluating research training outcomes: experience from the Cancer Prevention Fellowship Program at the National Cancer Institute. Academic Medicine 2006;81(6):535-541.
    [ PubMed Abstract ]
  • Dorgan JF, McMahon RP, Friedman LA, Van Horn L, Snetselaar LG, Kwiterovich PO, Lauer RM, Lasser NL, Stevens VJ, Robson A, Cooper SF, Chandler DW, Franklin FA, Barton BA, Patterson BH, Taylor PR, Schatzkin A. Diet and sex hormones in boys: findings from the dietary intervention study in children. J Clin Endocrinol Metab 2006;91(10):3992-3996.
    [ PubMed Abstract ]
  • Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice R, Patterson R, Carroll R, Subar AF. A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epidemiol 2006;35(4):1011-1021.
    [ PubMed Abstract ]
  • Izmirlian G. Response to "Receiver operating characteristics of the prostate-specific antigen test in an unselected population." J Med Screen 2006;13(4):214-215.
    [ PubMed Abstract ]
  • Lacey JV, Greene MH, Buys SS, Reding D, Riley TL, Berg CD, Fagerstrom RM, Hartge P. Ovarian cancer screening in women with a family history of breast or ovarian cancer. Obstet Gynecol 2006;108(5):1176-1184.
  • Marcus PM. Lung cancer screening. In: Jeffries LP (ed). Lung Cancer Screening. Hauppauge, NY:Nova Science Publishers, 2006;51-80.
  • Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006;98(11):748-756.
    [ PubMed Abstract ]
  • Millen AF, Midthune D, Thompson FE, Kipnis V, Subar AF. The National Cancer Institute diet history questionnaire: validation of pyramid food servings. Am J Epidemiol 2006;163(3):279-288.
  • Rosenfeld S. A nonlinear continuous stochastic model for genetic regulatory networks. caveats for microarray data analysis. Proceedings of the 10th International Conference on the Simulation and Synthesis of Living Systems, Bloomington, IN, June 3-7, 2006, pp. 28-34.
  • Rosenfeld S. Stochastic oscillations in genetic regulatory networks. EURASIP Journal of Bioinformatics and Systems Biology 2006;Article ID 59256:1-12.
  • Rosenfeld S. Stochastic oscillations in genetic regulatory networks. application to microarray experiments. In: A.Rizzi, M.Vichi (ed). Proceedings in Computational Statistics Proceedings COMPSTAT 2006. Rome, Italy:Physica-Verlag, 2006;1609-1618
    [ PubMed Abstract ]
  • Steele VE, Arnold JT, Le H, Izmirlian G, Blackman MR. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells. Anticancer Research 2006;26:3205-3216.
    [ PubMed Abstract ]
  • Subar AF, Dodd KW, Guenther PM, Kipnis V, Midthune D, McDowell M, Tooze JA, Freedman LS, Krebs-Smith SM. The food propensity questionnaire: concept, development, and validation for use as a covariate in a model to estimate usual food intake. J Am Diet Assoc 2006;106(10):1556-1563.
    [ PubMed Abstract ]
  • Thiébaut AC, Schatzkin A, Ballard-Barbash R, Kipnis V. Dietary fat and breast cancer: contributions from a survival trial. J Natl Cancer Inst 2006;98(24):1753-1755.
    [ PubMed Abstract ]
  • Tooze JA, Midthune D, Dodd KW, Freedman LS, Krebs-Smith SM, Subar AF, Guenther PM, Carroll RJ, Kipnis V. A new statistical method for estimating the usual intake of episodically consumed foods with application to their distribution. J Am Diet Assoc 2006;106(10):1575-1587.
    [ PubMed Abstract ]
  • Valente AXCN, Cusick ME. Yeast protein interactome topology provides framework for coordinated-functionality. Nucleic Acids Research 2006;34:2812-2819.
    [ PubMed Abstract ]
  • Vickers AJ, Kramer BS, Baker SG. Selecting patients for randomized trials: a systematic approach. Trials 2006;7:30.
    [ PubMed Abstract ]
  • Weiss NS, Doria-Rose VP. Colorectal cancer risk following a negative colonoscopy. JAMA 2006;296(20):2436-2438.
    [ PubMed Abstract ]
  • Xu J-L, Izmirlian G. Estimation of location parameters for spherically symmetric distributions. Journal of Multivariate Analysis 2006;97:514-525.

2005

  • Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK, for the PLCO Project Team. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 2005;97:433-438.
    [ PubMed Abstract ]
  • Baker SG. A simple loglinear model for haplotype effects in a case-control study involving two unphased genotypes. Statistical Applications in Genetics and Molecular Biology 2005;4(1):Article14.
    [ PubMed Abstract ]
  • Baker SG. Counterfactuals and the paired availability design. Posted comment for Causal inference based on counterfactuals by M Höfler. BMC Med Res Methodol 2005;5:28.
  • Baker SG. Response to letter "Re: The central role of the Receiver Operating Characteristic (ROC) curves in evaluating tests for the early detection of cancer". J Natl Cancer Inst 2005;97:234-235.
  • Baker SG, Izmirlian G, Kipnis V. Resolving paradoxes involving surrogate endpoints. J R Statist Soc A 2005;168(4):753-762.
  • Baker SG, Kramer BS. Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis. Stat Methods Med Res 2005;14:349-367.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Statistics for weighing benefits and harms in a proposed genetic substudy of a randomized cancer prevention trial. J R Statist Soc C (Applied Statistics) 2005;54(5):941-954.
  • Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics 2005;61(1):55-63.
    [ PubMed Abstract ]
  • Berger VW. A novel criterion for selecting covariates. Drug Information Journal 2005;39:233-241.
  • Berger VW. A review of methods for ensuring the comparability of comparison groups in randomized trials. Reviews on Recent Clinical Trials 2005;1(1):81-86.
    [ PubMed Abstract ]
  • Berger VW. Allocation concealment and blinding: when ignorance is bliss. Med J Aust 2005;183(3):165-166.
    [ PubMed Abstract ]
  • Berger VW. Nonparametric adjustment techniques for binary covariates. Biom J 2005;47(2):199-205.
    [ PubMed Abstract ]
  • Berger VW. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials (with discussion). Biom J 2005;47(2):119-127.
    [ PubMed Abstract ]
  • Berger VW. The reverse propensity score to detect selection bias and correct for baseline imbalances. Stat Med 2005;24(18):2777-2787.
    [ PubMed Abstract ]
  • Berger VW. Training statisticians to be alert to the dangers of mis-applying statistical methods when they do not apply. Journal of Modern Applied Statistical Methods 2005;4(2):587-590.
  • Berger VW. What is to be done about selection bias. Biom J 2005;47(2):136-139.
  • Berger VW, Durkalski VL. Analysis of trichotomous pharmaceutical endpoints. J Biopharm Stat 2005;15(4):739-745.
    [ PubMed Abstract ]
  • Berger VW, Hsieh G. Rethinking statistics: basing efficacy alpha levels on safety data in randomized trials. Israeli Journal of Emergency Medicine 2005;5(3):55-60.
  • Berger VW, Matthews JR. Conducting today's trials by tomorrow's standards. Pharmaceutical Statistics 2005;4:155-159.
  • Berger VW, Semanick L. Refining the assessment of the sensitivity and specificity of diagnostic tests, with applications to prostate cancer screening and non-small cell lung cancer staging. Rev Panam Salud Publica 2005;18(1):64-70.
    [ PubMed Abstract ]
  • Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, Hartge P, Fagerstrom RM, Ragard LR, Chia D, Izmirlian G, Fouad M, Johnson CC, Gohagan JK, for the PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193(5):1630-1639.
    [ PubMed Abstract ]
  • Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ. Modeling the dissemination of mammography in the United States. Cancer Causes Control 2005;16(6):701-712.
    [ PubMed Abstract ]
  • Gohagan JK, Marcus PM, Fagerstrom RM, Black WC, Kramer BS, Pinsky PF, Prorok PC. Screening for lung cancer. In Gibson PG, Abramson M, Wood-Baker R, Volmink J, Hensley M, Costabel U (eds). Evidence-Based Respiratory Medicine. Malden, MA:Blackwell Publishing, 2005;81-87.
  • Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C; the Lung Screening Study Research Group. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005;47(1):9-15.
    [ PubMed Abstract ]
  • Ivanova A, Barrier RC Jr, Berger VW. Adjusting for observable selection bias in block randomized trials. Stat Med 2005;24(10):1537-1546.
    [ PubMed Abstract ]
  • Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann NY Acad Sci 2004;1020:154-174.
    [ PubMed Abstract ]
  • Kafadar K, Prorok PC. Computational methods in medical decision making: to screen or not to screen? Stat Med 2005;24(4):569-581.
    [ PubMed Abstract ]
  • Marcus PM, Miedzinski M. Measuring the impact of HIPAA in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2005;14:549.
  • Marcus PM, Miedzinski M. Measuring the impact of HIPAA's Privacy Rule in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Am J Epidemiol 2005;61:S151.
  • Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A. Comparison of cancer registry ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Management 2005;32:70-75.
  • Midthune D, Fay MP, Clegg LX, Feuer EJ. Modeling reporting delays and reporting corrections in cancer registry data. J Am Stat Assoc 2005;100:61-70.
  • Oken MM, Marcus PM, Hu P, Beck TM, Hocking W, Kvale PA, Cordes J, Riley TL, Winslow SD, Peace P, Levin DL, Prorok PC, Gohagan JK for the PLCO Project Team. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst 2005;97(24):1832-1839.
    [ PubMed Abstract ]
  • Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC. Gohagan JK for the PLCO Project Team. Prostate biopsy following a positive screen in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Urol 2005;173:746-751.
    [ PubMed Abstract ]
  • Pinsky PF, Marcus PM, Kramer BS, Freedman M, Nath H, Kvale P, Reding D. Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen. Cancer 2005;103:157-163.
    [ PubMed Abstract ]
  • Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005;5(2):142-149.
    [ PubMed Abstract ]
  • Ransohoff DF. Lessons from controversy: ovarian cancer screening and serum proteomics. J Natl Cancer Inst 2005;97(4):315-319.
    [ PubMed Abstract ]
  • Thompson FE, Midthune D, Subar AF, McNeel T, Berrigan D, Kipnis V. Dietary intake estimates in the National Health Interview Survey, 2000: methodology, results, and interpretation. J Am Diet Assoc 2005;105(3):352-363; quiz 487.
    [ PubMed Abstract ]
  • Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK, PLCO Project Team. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97(13):989-997.
    [ PubMed Abstract ]
  • Xu J-L. On improved estimates of location in the presence of an unknown scale. In Fan J, Li G (eds). Contemporary Multivariate Analysis and Experimental Design -- In Honor Celebration of Professor Kai-Tai Fang's 65th Birthday. Singapore:The World Scientific Publisher, 2005;435-443.

2004

  • Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, PLCO Steering Committee. The Prostate, Lung, Colon, and Ovarian (PLCO) Cancer Screening Trial: status and promise. Urology Oncology 2004;22(4):358-361.
    [ PubMed Abstract ]
  • Baker SG. Cure model. Encyclopedia of Statistical Science. New York: John Wiley and Sons, 2004. DOI: 10.1002/0471667196.ess4040.
  • Baker SG, Freedman LS. Correction: a simple method for analyzing data from a randomized trial with a missing binary outcome. BMC Med Res Methodol 2004;4(1):1.
  • Baker SG, Kramer BS. Biomarkers, surrogate endpoints, and early detection imaging tests: reducing confusion. International Chinese Statistical Association Bulletin, January 2004.
  • Baker SG, Kramer BS, Corle D. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"? BMC Med Res Methodol 2004(Oct 4);4:24.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Prorok PC. Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design. BMC Med Res Methodol 2004(May 18);4(1):12.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Prorok PC. Development tracks for cancer prevention markers. Dis Markers 2004;20(2):97-102.
    [ PubMed Abstract ]
  • Berger VW. Does the Prentice criterion validate surrogate endpoints? Stat Med 2004;23(10):1571-1578.
    [ PubMed Abstract ]
  • Berger VW. On the generation and ownership of alpha in medical studies. Control Clin Trials 2004;25(6):613-619.
    [ PubMed Abstract ]
  • Berger VW. Selection bias and baseline imbalances in radomized trials. Drug Information Journal 2004;38:1-2.
  • Berger VW. Validate adjustment for binary covariates of randomized binary comparisons. Biom J 2004;46(5):589-594.
  • Berger VW, Ioannidis JP. The Decameron of poor research. Br Med J 2004;239:1436-1440.
    [ PubMed Abstract ]
  • Berger VW, Weinstein S. Ensuring the comparability of comparison groups: is randomization enough? Control Clin Trials 2004;25(5):515-524.
    [ PubMed Abstract ]
  • Berger VW, Zhou YY, Ivanova A, Tremmel L. Adjusting for ordinal covariates by including a partial ordering. Biom J 2004;46(1):48-55.
    [ PubMed Abstract ]
  • Freedman LS, Fainberg V, Kipnis V, Midthune D, Carroll RJ. A new method for dealing with measurement error in explanatory variables of regression models. Biometrics 2004;60(1):172-181.
    [ PubMed Abstract ]
  • Freedman LS, Midthune D, Carroll RJ, Krebs-Smith S, Subar AF, Troiano RP, Dodd K, Schatzkin A, Ferrari P, Kipnis V. Adjustments to improve the estimation of usual dietary intake distributions in the population. J Nutr 2004;134(7):1836-1843.
    [ PubMed Abstract ]
  • Fuchs C, Berger VW. Quantifying the proportion of cases attributable to an exposure. Journal of Modern Applied Statistical Methods 2004;3(1):54-64.
  • Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph. the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-112
    [ PubMed Abstract ]
  • Hu P, Zelen M. Planning of randomized early detection trials. Stat Methods Med Res 2004;13:419-506.
    [ PubMed Abstract ]
  • Imperiale TE, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross Imperiale TE, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714.
    [ PubMed Abstract ]
  • Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann NY Acad Sci 2004;1020:154-174.
    [ PubMed Abstract ]
  • Kapetanovic IM, Rosenfeld S, Izmirlian G. Overview of commonly used bioinformatics methods and their applications. Ann NY Acad Sci 2004;1020:10-21.
    [ PubMed Abstract ]
  • Krebs-Smith SM, Subar AF, Guenther P, Tooze JA, Midthune D, Kipnis V, Dodd K. Food propensity questionnaires (FPQs) in the National Health and Nutrition Examination Survey (NHANES): a step in the evolution of usual dietary intake estimation. FASEB J 2004;18:A480.
  • Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Evidence of overdiagnosis in lung cancer screening. Cancer Epidemiol Biomarkers Prev 2004;13:332.
  • Prentice RL, Willett WC, Greenwald P, Alberts D, Bernstein L, Boyd NF, Byers T, Clinton SK, Fraser G, Freedman L, Hunter D, Kipnis V, Kolonel LN, Kristal BS, Kristal A, Lampe JW, McTiernan A, Milner J, Patterson RE, Potter JD, Riboli E, Schatzkin A, Yates A, Yetley E. Nutrition and physical activity and chronic disease prevention: research strategies and recommendations. J Natl Cancer Inst 2004;96(17):1276-1287.
    [ PubMed Abstract ]
  • Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4(4):309-314.
    [ PubMed Abstract ]
  • Rosenfeld S. A new method for testing normality based on properties of hermite orthogonal polynomials. Proceedings of the 2004 International Conference of Statistics, Mathematics and Related Fields, Waikiki, HI, June 9-12, 2004, pp. 739-755 (ISSN#1550-3747).
  • Rosenfeld S. New developments in cancer-related computational statistics. Ann NY Acad Sci 2004;1020:22-31.
    [ PubMed Abstract ]
  • Rosenfeld S. Sampling from the bivariate gamma distribution with specified correlation coefficient and different marginal distributions. Proceedings of the 2004 International Conference of Statistics, Mathematics and Related Fields, Waikiki, HI, June 9-12, 2004, pp. 756-772 (ISSN#1550-3747).
  • Rosenfeld S, Wang T, Kim Y, Milner J. Numerical deconvolution of cDNA microarray signal: simulation study. Ann NY Acad Sci 2004;1020:110-123.
    [ PubMed Abstract ]
  • Schatzkin A, Kipnis V. Could exposure assessment problems give us wrong answers to nutrition cancer questions? J Natl Cancer Inst 2004;96(21):1564-1565.
    [ PubMed Abstract ]
  • Subar AF, Dodd K, Thompson FE, Kipnis V, Midthune D, Krebs-Smith SM. What, exactly, is the food propensity questionnaire? FASEB J 2004;18:A481.
  • Thompson FE, Midthune D, Subar AF, Kahle LL, Schatzkin A, Kipnis V. Performance of a short tool to assess dietary intakes of fruits and vegetables, percentage energy from fat and fibre. Public Health Nutr 2004;7(8):1097-1105.
    [ PubMed Abstract ]
  • Tooze JA, Dodd KN, Midthune D, Krebs-Smith SM, Subar AF, Kipnis V. Estimating the distribution of usual intake of episodically consumed foods using two 24-hour recalls and a food propensity questionnaire, FASEB J 2004;18:A481.
    [ PubMed Abstract ]
  • Tooze JA, Subar AF, Thompson FE, Troiano R, Schatzkin A, Kipnis V. Psychosocial predictors of energy underreporting in a large doubly labeled water study. Am J Clin Nutr 2004;79(5):795-804.
    [ PubMed Abstract ]
  • Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU. Serum proteomic profiles suggest celecoxib-modulated targets and response predictors. Cancer Res 2004;64(8):2904-2909.
    [ PubMed Abstract ]
  • Xu J-L, Fagerstrom RM, Prorok PC, Kramer BS. Estimating the cumulative risk of a false-positive test in a repeated screening program. Biometrics 2004;60:651-660.
    [ PubMed Abstract ]

2003

  • Baker SG. The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst 2003;95(7):511-515.
    [ PubMed Abstract ]
  • Baker SG, Chia-Wen K, Graubard B. A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey. Biostatistics 2003;1:41-56.
    [ PubMed Abstract ]
  • Baker SG, Erwin D, Kramer BS, Prorok PC. Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening. BMC Med Res Methodol 2003(6 Mar);3:4.
    [ PubMed Abstract ]
  • Baker SG, Freedman LS. A simple method for analyzing data from a randomized trial with a missing binary outcome. BMC Med Res Methodol 2003;3:8.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. A perfect correlate does not a surrogate make. BMC Med Res Methodol 2003;3:16.
  • Baker SG, Kramer BS. Correction: the transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Med Res Methodol 2003;3:23.
  • Baker SG, Kramer BS. Estimating the cumulative risk of false positive cancer screenings. BMC Med Res Methodol 2003(03 Jul),3:11.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes. BMC Medical Research Methodology 2003(16 Jun);3:10.
    [ PubMed Abstract ]
  • Berger VW. Additional reflections on significance testing. Journal of Modern Applied Statistical Methods 2003;2(2):5124-515.
  • Berger VW. Further analysis of the Gallin Itraconazole Trial. N Engl J Med 2003;349(12):1190-1191.
  • Berger VW, Bears J. When can a clinical trial be called 'randomized'? Vaccine 2003;21:468-472.
  • Berger VW, Christophi CA. Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias. Journal of Modern Applied Statistical Methods 2003;2(1):80-86.
  • Berger VW, Ivanova A, Knoll MD. Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Stat Med 2003;22(19):3017-3028.
    [ PubMed Abstract ]
  • Berger VW, Rezvani A, Makarewicz V. Direct effect on validity of response run-in selection in clinical trials. Control Clin Trials 2003;24(2):156-166.
    [ PubMed Abstract ]
  • Church TR (for the National Lung Screening Trial Executive Committee). Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003;10:713-715.
    [ PubMed Abstract ]
  • Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich Jr. PO, Lauer RM, Van Horn L, Lasser NL, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A, Taylor PR. Diet and sex hormones in girls: findings from a randomized controlled clinical trial. J Natl Cancer Inst 2003;95(2):132-141.
    [ PubMed Abstract ]
  • Fagerstrom RM, Marcus PM, Prorok PC, Kramer BS, Greenwald P, Gohagan JK. Issues in the design, operations, and analysis of multi-disease screening trials: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Experience. Controlled Clinical Trials 2003;24:57S.
  • Forman MR, Ballard-Barbash R, Kipnis V. Nutritional strategies for breast cancer prevention: what have we learned and where do we go from here? Cancer 2003;98(9):1782-1785.
    [ PubMed Abstract ]
  • Gohagan JK, Marcus PM, Fagerstrom RM, Black WC, Kramer BS, Pinsky PF, Prorok PC. Screening for lung cancer. In Williams C (ed). Evidence-Based Oncology. London:BMJ Books, 2003;164-171.
  • Gulyaeva N, Zaslavsky A, Lechner P, Chlenov M, McConnell O, Chait A, Kipnis V, Zaslavsky B. Relative hydrophobicity and lipophilicity of drugs measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. a simple model for predicting blood—brain distribution. Eur J Medicinal Chemistry 2003;38(4):391-396.
    [ PubMed Abstract ]
  • Kafadar K, Prorok PC. Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials. Stat Med 2003;22:83-111.
    [ PubMed Abstract ]
  • Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, Troiano RP, Bingham S, Schoeller DA, Schatzkin A, Carroll RJ. Structure of dietary measurement error: results of the OPEN Biomarker Study. Am J Epidemiol 2003;158(1):14-21.
    [ PubMed Abstract ]
  • Kipnis V, Subar AF, Schatzkin A, Midthune D, Troiano RP, Schoeller DA, Bingham S, Freedman LS. Kipnis et al. respond to "OPEN questions". Am J Epidemiol 2003;158(1):25-26.
  • Kvale PA, Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. The lung screening study: The National Cancer Institute's randomized feasibility study of spiral CT versus chest x-ray in lung cancer screening. Chest 2003;124:118S-118S.
  • Marcus PM. Conflicting evidence in lung cancer screening: randomized controlled trials versus case-control studies. Lung Cancer 2003;41:37-39.
    [ PubMed Abstract ]
  • Marcus P, Fagerstrom R, Church T, Prorok P, Gohagan J. Choosing a control-arm intervention in cancer screening trials when standard of care is unclear. Controlled Clinical Trials 2003;24:224S.
  • Michaud DS, Troiano RP, Subar AF, Runswick S, Bingham S, Kipnis V, Schatzkin A. Comparison of estimated renal net acid excretion from dietary intake and body size with urine pH. J Am Diet Assoc 2003;103(8):1001-1007.
    [ PubMed Abstract ]
  • Ransohoff DF. Developing molecular biomarkers for cancer. Science 2003;299:1679-1680.
    [ PubMed Abstract ]
  • Schatzkin A, Kipnis V, Carroll RJ, Midthune D, Subar AF, Bingham S, Schoeller DA, Troiano RP, Freedman LS. A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) study. Int J Epidemiol 2003;32(6):1054-1062.
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK, for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003;290(1):41-48.
    [ PubMed Abstract ]
  • Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S, Sharbaugh CO, Trabulsi J, Runswick S, Ballard-Barbash R, Sunshine J, Schatzkin A. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003;258(1):1-13.
    [ PubMed Abstract ]
  • Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Burt R, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A; Polyp Prevention Study Group. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 2003;14(5):403-411.
    [ PubMed Abstract ]
  • Trabulsi J, Troiano RP, Subar AF, Sharbaugh C, Kipnis V, Schatzkin A, Schoeller DA. Precision of the doubly labeled water method in a large-scale application: evaluation of a streamlined-dosing protocol in the Observing Protein and Energy Nutrition (OPEN) study. Eur J Clin Nutr 2003;57(11):1370-1377.
    [ PubMed Abstract ]
  • Xu J-L, Prorok PC. Modelling and analysing exchangeable binary data with random cluster sizes. Stat Med 2003;22:2401-2416
    [ PubMed Abstract ]

2002

  • Baker SG, Kramer BS. The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C? BMC Medical Research Methodology 2002(13 Nov);2(1):13.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Prorok PC. Statistical issues in randomized trials of cancer screening. BMC Medical Research Methodology 2002 (19 Sept);2:11.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Srivastava S. Markers for early detection of cancer: Statistical issues for nested case-control studies. BMC Medical Research Methodology 2002;2:4.
    [ PubMed Abstract ]
  • Baker SG, Tockman MS. Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention. Statistics in Medicine 2002;21:2383-2390.
    [ PubMed Abstract ]
  • Berger VW. Improving the information content of categorical clinical trial endpoints. Controlled Clinical Trials 2002;23:502-514.
    [ PubMed Abstract ]
  • Berger VW, Ivanova A. Adaptive tests for ordinal data. Journal of Modern Applied Statistical Methods 2002;1(2):269-280.
  • Berger VW, Ivanova A. Bias of linear rank tests for stochastic order in ordered categorical data. Journal of Statistical Planning and Inference 2002;107(1):237-247.
  • Berger VW, Lunneborg C, Ernst MD, Levine JG. Parametric analyses in randomized clinical trials. Journal of Modern Applied Statistical Methods 2002:1(1):74-82.
  • Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-1545.
    [ PubMed Abstract ]
  • de Koning HJ, Auvinen A, Sanchez AB, da Silva FC, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH for the ERSPC and the PLCO Trials: Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer Trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial. Int J Cancer 2002;97:237-244.
    [ PubMed Abstract ]
  • Dorgan JF, Fears T, McMahon RP, Friedman LA, Patterson BH, Greenhut S. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002;67:151-158.
    [ PubMed Abstract ]
  • Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, Daly AK, Heckbert SR, Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA, Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156(2):95-109.
    [ PubMed Abstract ]
  • Kipnis V, Izmirlian G. The impact of categorization of continuous exposure measured with error. Am J Epidemiol 2002;155:S28.
  • Kipnis V, Izmirlian G, Midthune D, Subar A, Schatzkin A. Misclassification of dietary exposure and its implications: results from the Observing Protein and Energy Nitrition (OPEN) biomarker study. Am J Epidemiol 2002;155:S28.
  • Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ. Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutrition 2002;5:915-923.
    [ PubMed Abstract ]
  • Marcus PM. Lung cancer screening, once again (letter). Chest 2002;122:3.
    [ PubMed Abstract ]
  • Marcus PM, Fagerstrom RM, Prorok PC, Gohagan JK, Kramer BS. Screening for lung cancer with helical CT scanning. Clinical Pulmonary Medicine 2002;9:323-329.
  • Marcus PM, Travis WD. Lung. In Franco EL, Rohan TE (eds). Cancer Precursors. New York, NY: Springer-Verlag, 2002:201-219.
  • Patterson BH, Dayton CM, Graubard BI. Latent class analysis of complex sample survey data: Application to dietary data. Journal of the American Statistical Society 2002;97:721-734.
    [ PubMed Abstract ]
  • Patterson BH, Dayton CM, Graubard BI. Rejoinder. Journal of the American Statistical Society 2002;738-741.
  • Potischman N, Coates RJ, Swanson CA, Carroll RJ, Daling JR, Brogan DR, Gammon MD, Midthune D, Curtin J, Brinton LA. Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States. Cancer Causes Control 2002;13:937-946.
    [ PubMed Abstract ]
  • Ransohoff DF. Challenges and opportunities in evaluating diagnostic tests. J Clin Epid 2002;55:1178-1182.
    [ PubMed Abstract ]
  • Schatzkin A, Kipnis V, Subar A, Troiano R, Midthune D, Bingham S, Schoeller D. Food frequency questionnaire may seriously attenuate association between diet and disease: results from the OPEN (Observing Protein and Energy Nutrition) biomarker study. Am J Epidemiol 2002;155:S28.
  • Shike M, Latkany L, Riedel E, Fleisher M, Schatzkin A, Lanza E, Corle D, Begg CB, the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. Journal of Clinical Oncology 2002;20(17):3592-3598.
    [ PubMed Abstract ]
  • Stables GJ, Subar AF, Patterson BH, Dodd K, Heimendinger J, Van Duyn MA, Nebeling L. Changes in vegetable and fruit consumption and awareness among US adults. results of the 1991 and 1997 5 A Day for Better Health Program surveys. J Am Diet Assoc 2002;102(6):809-817.
    [ PubMed Abstract ]
  • Thompson FE, Subar AF, Smith AF, Midthune D, Radimer KL, Kahle LL, Kipnis V. Fruit and vegetable assessment: Performance of 2 new short instruments and a food frequency questionnaire. J Am Diet Assoc 2002;102:1764-1772.
    [ PubMed Abstract ]
  • Thomson FE, Patterson BH, Weinstein SJ, McAdams M, Spate VL, Hamman RF, Levine RS, Mallin K, Stolley PD, Brinton LA, Morris JS, Ziegler RG. Serum selenium and the risk of cervical cancer among women in the United States. Cancer Causes and Controls 2002;13:517-526.
    [ PubMed Abstract ]
  • Tooze J, Subar A, Thompson F, Troiano R, Schatzkin A, Kipnis V. Psychosocial predictors of energy underreporting in a large doubly labeled water study. Am J Epidemiol 2002;155:S56.
    [ PubMed Abstract ]
  • Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok PC. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Cancer 2002;94:2569-2576.
    [ PubMed Abstract ]

2001

  • Baker SG. Discussion of doubling sampling with survival analysis. Biometrics 2001;57:348-350.
  • Baker SG. Evaluating periodic cancer screening without a randomized control group: a simplified design and analysis. In: Duffy SW, Hill C, Esteve J (eds). Quantitative Methods for the Evaluation of Cancer Screening. London: Edward Arnold Limited, 2001;34-41.
  • Baker SG, Kramer BS. Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies. Journal of Women's Health & Gender-Based Medicine 2001;10:867- 872.
    [ PubMed Abstract ]
  • Baker SG, Lindeman KL, Kramer BS. The paired availability design for historical controls. BMC Medical Research Methodology 2001;1:9.
  • Baker SG, Lindeman KL. Rethinking historical controls. Biostatistics 2001,2:383-396.
  • Baker SG, Lindeman, KS. Randomized and nonrandomized studies. statistical considerations (editorial). Anesthesiology 2000;92:928-930.
  • Baker SG, Pinsky P. A proposed design and analysis for comparing digital and analog mammography: special ROC methods for cancer screening. Journal of the American Statistical Association 2001;96:421-428.
  • Berger VW. The p-value interval as an inferential tool. Journal of the Royal Statistical Society D 2001;50(1):79-85.
  • Berger VW, Ivanova A. Permutation tests for phase III clinical trials. In: Millard SP, Krause A (eds). Applied Statistics in the Pharmaceutical Industry with Case Studies Using S-PLUS. New York: Springer-Verlag, New York, 2001;349-374.
  • Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001;37:261-267.
    [ PubMed Abstract ]
  • Corle DK, Sharbaugh C, Mateski DJ, Coyne T, Paskett ED, Cahill J, Daston C, Lanza E, Schatzkin A, the PPT Study Group. Self-rated quality of life measures: effect of change to a low-fat, high-fiber, fruit and vegetable enriched diet. Ann Behav Med 2001;23(3):198-207.
    [ PubMed Abstract ]
  • Frangakis C, Baker SG. Compliance adjusted double-sampling designs for comparative research: estimation and optimal planning. Biometrics 2001;57:899-908.
    [ PubMed Abstract ]
  • Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL. Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology 2001;58:561-566.
    [ PubMed Abstract ]
  • Honkanen V, Szalai JP, Siegel JN, Siegel A, Berger VW, Feldman BM. A three-phase clinical trial design for rare disorders. Statistics in Medicine 2001;20:3009-3021.
  • Ivanova A, Berger V. Drawbacks to integer scoring for ordered categorical data. Biometrics 2001;57:567-570.
    [ PubMed Abstract ]
  • Jiang WX, Kipnis V, Midthune D, Carroll RJ. Parameterization and inference for nonparametric regression problems. Journal of the Royal Statistical Society, Series B 2001;63(3):583-591.
  • Kipnis V, Midthune D, Freedman LS, Bingham S, Subar A, Schatzkin A, Carroll RJ. Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol 2001;153:394-403.
    [ PubMed Abstract ]
  • Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R, Caan B, Lance P, Marshall J, Iber F, Shike M, Weissfeld J, Slattery M, Paskett E, Mateski D, the PPT Study Group. Implementation of a 4-year high fiber, high fruit/vegetable, low fat dietary intervention: results of dietary change in the Polyp Prevention Trial. Am J Clin Nutr 2001;74(3):387-401.
    [ PubMed Abstract ]
  • Marcus PM. Lung cancer screening: an update. J Clin Oncol 2001;19S:83S-86S.
    [ PubMed Abstract ]
  • Marcus PM, Fagerstrom RF, Prorok PC. Response to multiple correspondence in response to: Lung cancer mortality in the Mayo Lung Project: the impact of extended follow-up. J Natl Cancer Inst 2001;93:322.
  • McShane LM, Midthune DN, Dorgan JF, Freedman LS, Carroll RJ. Covariate measurement error adjustment for matched case-control studies. Biometrics 2001;57:62-73.
    [ PubMed Abstract ]
  • Melzer D, Izmirlian G, Leveille SG, Guralnik JM. Educational differences in the prevalence of mobility disability in old age: the dynamics of incidence, mortality, and recovery. Journal of Gerontology: SOCIAL SCIENCES 2001;56B(5):S294-S301.
    [ PubMed Abstract ]
  • Potosky AL, Feuer EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001;23(1):181-186.
    [ PubMed Abstract ]
  • Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V. Design and serendipity in establishing a large cohort with wide dietary intake distributions - the National Institutes of Health-American Association of Retired Persions Diet and Health Study. Am J Epidemiol 2001;154(12):1119-1125.
    [ PubMed Abstract ]
  • Spiegelman D, Carroll R, Kipnis V. Efficient regression calibration for logistic regression for main study/internal validation study designs with an imperfect reference instrument. Stat Med 2001;20:139-160.
    [ PubMed Abstract ]
  • Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001;154(12):1089-1099.
    [ PubMed Abstract ]
  • Subar AF, Thompson FE, Kipnis V. Subar et al. respond to "A further look at dietary questionnaire validation" and "Another perspective on food frequency questionnaires". Am J Epidemiol 2001;154(12):1105-1106.

2000

  • Baker SG. Analyzing a randomized cancer prevention trial with a missing binary outcome, an auxiliary variable, and all-or-none compliance. J Am Stat Assoc 2000;95:43-50.
  • Baker SG. Identifying combinations of cancer biomarkers for further study as triggers of early intervention. Biometrics 2000;56:1082-1087.
    [ PubMed Abstract ]
  • Baker SG. Sample size is more than number crunching. SOAP Newsletter. Winter 2000.
  • Baker SG. Surrogate endpoints: illusion and reality. SOAP Newsletter. Fall 2000.
  • Baker SG, Lindeman KS. Randomized and nonrandomized studies. Statistical considerations (editorial). Anesthesiology 2000;92:928-30.
  • Berger VW. Critique of Ludbrook and Dudley. American Statistician 2000;54(1):85-86.
  • Berger VW. Pros and cons of permutation tests. Stat Med 2000;19:1319-1328.
    [ PubMed Abstract ]
  • Buyske S, Fagerstrom R, Ying Z. A class of weighted log-rank tests for survival data when the event is rare. J Am Stat Assoc 2000;95:249-258.
  • Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. Am J Epidemiol 2000;151(10):991-998.
    [ PubMed Abstract ]
  • Gohagan JK, Levin DL, Prorok PC, Sullivan D (eds). The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):249S-406S.
  • Gohagan JK, Prorok PC, Hayes R, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000;21(6 Suppl):251S-272S.
    [ PubMed Abstract ]
  • Hartge P, Hayes R, Reding D, Sherman ME, Prorok P, Schiffman M, Buys S. Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial. Am J Obstet Gynecol 2000;183(5):1232-1237.
    [ PubMed Abstract ]
  • Hasson MA, Fagerstrom RM, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):329S-348S.
    [ PubMed Abstract ]
  • Havlik RJ, Izmirlian G, Petrovitch H, Ross GW, Masaki K, Curb JD, Saunders AM, Foley DJ, Brock DB, Launer LJ, White L. APOE-epsilon4 predicts incident AD in Japanese-American men: the Honolulu-Asia Aging Study. Neurology 2000;54;1526-1529.
    [ PubMed Abstract ]
  • Izmirlian G, Brock DB, Ferrucci L, Phillips C. Active life expectancy from annual follow-up data with missing responses. Biometrics 2000;56(1):244-248
    [ PubMed Abstract ]
  • Izmirlian G, Brock DB, White L. Estimating incidence of dementia sub-types: assessing the impact of missed cases. Stat Med 2000;19:1577-1591.
    [ PubMed Abstract ]
  • Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with application to cancer rates. Stat Med 2000;19:335-351.
    [ PubMed Abstract ]
  • Kipnis V, Carroll RJ, Freedman LS, Li L. Re: "Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies" The authors reply (letter). Am J Epidemiol 2000;152:495-496.
  • Kulldorff M, McShane LM, Schatzkin A, Freedman LS, Wargovich MJ, Woods C, Purewal M, Burt RW, Lawson M, Mateski DJ, Lanza E, Corle DK, O'Brien B, Moler J. Measuring cell proliferation in the rectal mucosa. comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays. J Clin Epidemiol 2000;53(8):875-883.
    [ PubMed Abstract ]
  • Leveille SG, Pennix BW, Melzer D, Izmirlian G, Guralnik JM. Sex differences in the prevalence of mobility misability in old age: the dynamics of incidence, recovery and mortality. J Gerontol B Psychol Sci Soc Sci 2000;55(1):S41-S50.
    [ PubMed Abstract ]
  • Marcus PM. Television as a venue for cancer education: the General Hospital experience. J Cancer Educ 2000;15:4.
    [ PubMed Abstract ]
  • Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-1316.
    [ PubMed Abstract ]
  • Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000;9(5):461-467.
    [ PubMed Abstract ]
  • Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B. The association of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk. Cancer Causes Control 2000;11:271-278.
    [ PubMed Abstract ]
  • Marcus PM, Rothman N, Caporaso N. CYP2D6 (debrisoquine metabolism) and lung cancer histology. Am J Epidemiol 2000;151:S25.
  • Marcus PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 studies. Pharmacogenetics 2000;10:115-122.
    [ PubMed Abstract ]
  • Masaki K, Losonsczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik RJ, White L. Association of vitamin E and C supplement use with cognitive function and dementia in elderly Japanese-American men: the Honolulu-Asia Aging Study. Neurology 2000;54(6):1265-1272
    [ PubMed Abstract ]
  • Masaki KH, White LR, Foley DJ, Petrovitch H, Izmirlian G, Havlik R, Ross GW, Losonczy KG. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men - Reply. Neurology 2000;55(6):901-902.
    [ PubMed Abstract ]
  • O'Brien B, Nichaman L, Browne JEH, Levin DL, Prorok PC, Gohagan JK. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):310S-328S.
    [ PubMed Abstract ]
  • Permutt T, Berger VW. Rank tests in ordered 2xk contingency tables. Communications in Statistics, Theory and Methods 2000;29(5):989-1003.
  • Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 2000;21:57-62
    [ PubMed Abstract ]
  • Prorok PC, Andriole GL, Bresalier R, Buys S, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes R, Johnson CC, Mandel JS, O'Brien B, Oken M, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):273S-309S.
    [ PubMed Abstract ]
  • Rosenfeld S, Grody N. Metamorphic signature of snow revealed in SSM/I measurements. IEEE Transactions on Geoscience and Remote Sensing 2000;38(1):53-63.
  • Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J, the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber, fruit- and vegetable-enriched diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342(16):1149-1155.
    [ PubMed Abstract ]
  • Stein, M, Rich J, Maksad J, Chen MH, Hu P, Sobota M, Clark J. Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000;26(2):195-205.
    [ PubMed Abstract ]
  • Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, Schatzkin A. Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 2000;152:279-286.
    [ PubMed Abstract ]
  • Thompson FE, Kipnis V, Subar AF, Krebs-Smith SM, Kahle LL, Midthune D, Potischman N, Schatzkin A. Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am J Clin Nutr 2000;71:1503-1510.
    [ PubMed Abstract ]
  • Weissfeld JL, Fagerstrom RM, O'Brien B. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):390S-399S.
    [ PubMed Abstract ]

1999

  • Ballard-Barbash R, Forman MR, Kipnis V. Dietary fat, serum estrogen levels, and breast cancer risk: a multifaceted story. J Natl Cancer Inst 1999;91:492-494.
  • Berger VW, Exner DV. Detecting selection bias in randomized clinical trials. Control Clin Trials 1999;20:319-327.
  • Block G, Mangels AR, Patterson BH, Levander OA, Norkus EP, Taylor PR. Body weight and prior depletion affect ascorbate levels attained on identical vitamin C intake: a controlled-diet study. J Amer College of Nutr 1999;18:628-637.
  • Chu KC, Baker SG, Tarone RE. A method for identifying rapid changes in U.S. cancer mortality trends. Cancer 1999;86:157-169.
  • Corti MC, Guralnik JM, Ferrucci L, Izmirlian G, Leveille SG, Pahor M, Cohen HJ, Pieper C, Havlik RJ. Evidence for a black-white cross-over in all-cause and coronary heart disease mortality from a prospective study of an older population: the North Carolina EPESE. Am J Public Health 1999;89(3):308-314.
  • Ferrucci L, Izmirlian G, Leveille SG, Phillips CL, Corti MC, Brock DB, Guralnik JM. The effects of smoking and exercise on active life expectancy. Am J Epidemiol 1999;149:545-653.
  • Foley DJ , Monjan AA, Izmirlian G, Hays JC, Blazer DG. Incidence and remission of insomnia among elderly adults in a biracial cohort. Sleep 1999;22(Suppl 2):S373-S378.
  • Gail MH, Kessler LG, Midthune DN, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and mortality. Biometrics 1999;55:1137-1144.
  • Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS. Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999;91(12):1017-1024.
  • International Prostate Screening Trial Evaluation Group. Rationale for randomised trials of prostate cancer screening. European J Cancer 1999;35:262-271.
  • Kipnis V, Carroll RJ, Freedman LS, Li L. Implications of a new dietary measurement error model for estimation of relative risk: application to four validation studies. Am J Epidemiol 1999;150:642-651.
  • Kramer BS, Gohagan JK, Prorok PC (eds). Cancer Screening: Theory and Practice. New York: Marcel Dekker, 1999.
  • Marcus PM, Baird DD, Millikan RC, Moorman PC, Qaqish B, Newman B. Adolescent reproductive events and subsequent breast cancer risk. Am J Public Health 1999;89:1244-1248.
  • Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Sternfeld B, Qaqish B. Physical activity at age 12 and adult breast cancer risk (United States). Cancer Causes Control 1999;10:293-302.
  • Marcus PM, Prorok PC. Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification. J Med Screen 1999;6:47-49.
  • Prorok PC, Kramer BK, Gohagan JK. Screening theory and study design: the basics. In: Kramer BS, Gohagan JK, Prorok PC (eds). Cancer Screening: Theory and Practice. New York: Marcel Dekker, 1999;29-53.
  • Weerahandi S, Berger VW. Exact inference for growth curves with intraclass correlation structure. Biometrics 1999;55(3):921-924.
  • Xu J-L, Fagerstrom RM, Prorok PC. Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survival. Stat Med 1999;18:155-162.

1998

  • Baker SG, Connor RJ, Kessler LG. The partial testing design: a less costly way to test equivalence for sensitivity and specificity. Stat Med 1998;17:2219-2232.
  • Baker SG. Analysis of survival data from a randomized trial with all-or-none compliance: estimating the cost-effectiveness of a cancer screening program. J Am Stat Assoc 1998;93:929-934.
  • Baker SG. Confidence intervals. SOAP Newsletter. Spring 1998.
  • Baker SG. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screens. Biometrics 1998;54:1569-1578.
  • Baker SG. Multinomial-Poisson transformation. The Encyclopedia of Statistical Science, Update Volume 2. New York: John Wiley and Sons, 1998;416-418.
  • Baker SG. The correct and incorrect use of logistic regression. SOAP Newsletter. Winter 1998.
  • Baker SG. The paired availability design: an update. In: Abel U, Koch A (eds). Nonrandomized Comparative Clinical Studies. Dusseldorf: Medinform-Verlag, 1998;79-84.
  • Berger V, Permutt T, Ivanova A. The convex hull test for ordered categorical data. Biometrics 1998;54(4):1541-1550.
  • Berger V, Song J. Randomized clinical trials for the study of traditional Chinese medicine. The Bio/Pharma Quarterly of the Society of Chinese Bioscientists in America 1998;4(2):2-4.
  • Berger V. Admissibility of exact conditional tests of stochastic order. Journal of Statistical Planning and Inference 1998;66(1):39-50.
  • Carroll RJ, Freedman LS, Kipnis V, Li L. A new class of measurement error models, with applications to estimating the distribution of usual nutrient intake. Can J Stat 1998;26:467-477.
  • Carroll RJ, Freedman LS, Kipnis V. Measurement error and dietary intake. Adv Exp Med Biol 1998;139-145.
  • Cohen CJ, Iwane MK, Palensky JB, Levin DL, Meagher KJ, Frost KR, Mayer KH for the American Foundation for AIDS Research Community-Based Clinical Trials Network. A national HIV community cohort: design, baseline, and follow-up of the AmFAR observational database. J Clin Epidemiol 1998;51(9):779-793.
  • Cronin KA, Weed DL, Connor RJ, Prorok PC. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 1998;90:498-504.
  • Fay MP, Graubard BI, Freedman LS, Midthune DN. Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics 1998;54:195-208.
  • Kafadar K, Prorok PC, Smith PJ. An estimate of the variance of estimators for lead time and screening benefit time in randomized cancer screening trials. Biometrical Journal 1998;40:801-821.
  • Kipnis V, Carroll RJ, Freedman LS, Li L. The impact of realistic measurement error modeling on the analysis of dietary studies. Eur J Clin Nutr 1998;52(suppl 2):S79.
  • Kipnis V, Subar AF, Brown CC, Thompson FE, Schatzkin A, Carroll RJ, Freedman LS, McNutt S, Midthune D. Analysis of the calibration study of the National Institutes of Health--American Association of Retired Persons (NIH--AARP) diet and health study. Eur J Clin Nutr 1998;52(suppl 2):S42.
  • Marcus PM, Newcomb PA. The association of calcium and vitamin D with colon and rectal cancer. Int J Epidemiol 1998;27:788-793.
  • Marcus PM, Savitz DA, Millikan RC, Morgenstern H. The association of total trihalomethanes in drinking water and breast cancer in North Carolina women. Epidemiology 1998;9:156-160.
  • McShane LM, Kulldorff M, Wargovich MJ, Woods C, Purewal M, Freedman LS, Corle DK, Burt RW, Mateski DJ, Lawson M, Lanza E, O'Brien B, Lake W Jr, Moler J, Schatzkin A. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise? Cancer Epidemiol Biomarkers Prev 1998;7(7):605-612.
  • Prorok PC. Evaluation of screening benefit. In: Armitage P, Colton T (eds). Encyclopedia of Biostatistics, Vol. 5. New York: John Wiley and Sons, 1998;3976-3985.
  • Prorok PC. Screening trials. In: Armitage P, Colton T (eds). Encyclopedia of Biostatistics, Vol. 5. New York: John Wiley and Sons, 1998;3992-3999.
  • Rantanen T, Guralnick JM, Izmirlian G, Williamson J, Simonsick E, Ferrucci L, Fried L. Association of muscle strength with maximum walking speed in disabled older women. Am J Phys Med Rehabil 1998;77:299-305.
  • Rantanen T, Guralnick JM, Leveille SG, Izmirlian G, Hirsch R, Simonsick E, Ling S, Fried L. Racial differences in muscle strength in disabled older women. J Gerontol A Biol Sci Med Sci 1998;53(5):B355-B361.
  • Rantanen T, Masaki K, Foley D, Izmirlian G, White L, Guralnik JM. Grip strength changes over 27 yr in Japanese-American men. J Appl Physiol 1998;85(6):2047-2053.
  • Schatzkin A, Subar AF, Tompson FE, Harlan L, Freedman L, Kipnis V, Tangrea J, Hurwitz P. A new large cohort with wide intake distributions for nutrients and foods: the National Institutes of Health--American Association of Retired Persons (AARP) diet and health study. Eur J Clin Nutr 1998;52(suppl 2):S78.
  • Schoen RE, Corle D, Cranston L, Weissfeld JE, Lance P, Burt R, Iber F, Shike M, Kikendall JW, Hasson M, Lewin KJ, Appelman HD, Paskett E, Selby JV, Lanza E, Schatzkin A, for the Polyp Prevention Trial. Is colonoscopy needed for the non-advanced adenoma found on sigmoidoscopy? Gastroenterology 1998;115:533-541.
  • Taylor SM, Ross NA, Cummings KM, Glasgow RE, Goldsmith CH, Zanna MP, Corle DK. Community Intervention Trial for Smoking Cessation (COMMIT): changes in community attitudes toward cigarette smoking. Health Educ Res 1998;13(1):109-122.
  • Thompson B, Rich LE, Lynn WR, Shields R, Corle DK. A Voluntary Smokers' Registry: characteristics of joiners and non-joiners in the Community Intervention Trial for Smoking Cessation (COMMIT). Am J Public Health 1998;88(1):100-103.
  • Tompson FE, Kipnis V, Subar AF, Schatzkin A, Potischman N, Kahle L, McNutt S. Performance of a short instrument to estimate usual dietary intake of percent calories from fat. Eur J Clin Nutr 1998;52(suppl 2):S63.
  • Tompson FE, Subar AF, Kipnis V, Krebs-Smith S, Potischman N, Schatzkin A, McNutt S, Kahle L. Performance of two short instruments to estimate daily number of servings of fruit and vegetables. Eur J Clin Nutr 1998;52(suppl 2):S45.
  • Wastney ME, Patterson BH, Linares OA, Grei PC, Bosto RC (eds). Investigating Biological Systems Using Modeling. New York: Academic Press, 1998.
  • Xu J, Prorok PC. Estimating a distribution function of the tumor size at metastasis. Biometrics 1998;54:859-864.
  • Xu J-L. On a characterization of the normal distribution by a property of order. Sankhya 1998;60(Ser A):145-149.
  • Xu J-L. Characterizations of the exponential distribution via the blocking time in a queueing system with an unreliable server. Journal of Applied Probability 1998;35:236-239.

1997

  • Baker SG. Compliance, all-or-none. In: Kotz S, Read CR, Banks DL (eds). The Encyclopedia of Statistical Science, Update Volume 1. New York: John Wiley and Sons, 1997;134-138.
  • Baker SG. The correct and incorrect use of meta-analysis. SOAP Newsletter. Winter 1997.
  • Berger V, Sackrowitz H. Improving tests for superior treatment in contingency tables. J Am Stat Assoc 1997;92(438):700-705.
  • Breslow RA, Subar AF, Patterson BH, Block G. Trends in food intake: the 1987 and 1992 National Health Interview Surveys. Nutr Cancer 1997;28:86-92
  • Fay MP, Freedman LS, Clifford C, Midthune DN. Effect of different types and amounts of fat on the development of mammary tumors in rats: a review. Cancer Res 1997;57:3979-3988.
  • Freedman LS, Gail MH, Green SB, Corle DK. The efficiency of the matched-pairs design of the Community Intervention Trial for Smoking Cessation (COMMIT). Control Clin Trials 1997;18(2):131-9.
  • Freedman LS, Kipnis V, Brown CC, Schatzkin A, Wacholder S, Hartman A. Comments on "Adjustment for total energy intake in epidemiologic studies". Am J Clin Nutr l997;65(suppl):1229S-1231S.
  • Hyland A, Cummings KM, Lynn WR, Corle D, Giffen CA. Effect of proxy-reported smoking status on population estimates of smoking prevalence. Am J Epidemiol 1997;145(8):746-751.
  • Izmirlian G, Adewuyi AA, Suchindran CM. Analysis of contraceptive discontinuation in 6 developing countries. Soc Biol 1997;44(1-2):124-135.
  • Izmirlian G, Brock DB, Ferrucci L, Phillips C. Active life expectancy from annual follow-up data with missing responses. Proceedings of the American Statistical Association, Social Statistics Section 1997;159-164.
  • Kafadar K, Prorok PC. Estimating the difference in location parameters of two survival curves, with applications to cancer screening. Journal of Statistical Planning and Inference 1997;57:165-179.
  • Kipnis V, Freedman LS, Brown CC, Hartman A, Schatzkin A, Wacholder S. Effect of measurement error on energy-adjustment models in nutritional epidemiology. Am J Epidemiol 1997;146:842-855.
  • Korn EL, Graubard BI, Midthune DN. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
  • Korn EL, Midthune DN, Graubard BI. Estimating interpolated percentiles from grouped data with large samples. Journal of Official Statistics 1997;13:385-400.
  • Kramer BS, Gohagan JK, Prorok PC. Is screening for prostate cancer the current gold standard? - "no". Eur J Cancer 1997;33:348-353.
  • Patterson BH, Krebs-Smith SM, Subar AF, Corrections and revision of conclusions - dietary trends in the United States. N Engl J Med 1997;337:1846-1848.
  • Patterson BH, Levander OA. Naturally-occurring selenium compounds in cancer chemoprevention trials: a workshop summary. Cancer Epidemiol Biomakers Prev 1997;6(1):63-69.
  • Rosenfeld S. Analytical model of refraction in a moist polytropic atmosphere for space and ground-based GPS applications. National Environmental Satellite Data and Information Service, Technical Report #88, 1997.
  • Ross R, Rosenfeld S. Estimating mean weighted temperature of the atmosphere for GPS applications. JGR 1997;102(D18):21719-21730.
  • Roth MJ, Liu SF, Dawsey SM, Zhou B, Copeland C, Wang GQ, Solomon D, Baker SG, Giffen CA, Taylor PR. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer 1997;80(11):2047-2059.
  • White SN, Yu Z, Li ZC, Kipnis V. Mechanical fatigue parameters of three dental porcelains. J Dent Res 1997;76:138.
  • White SN, Yu Z, Li ZC, Kipnis V. Relationship between static chemical and cyclic mechanical fatigue in a feldspathic dental porcelain. Dent Mater 1997;13:103-10.
  • Xu J, Prorok PC. Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection. Biometrics 1997;53:579-591.
  • Xu J-L, Yang GL. An exponential characterization based on type II censored sample. Statistics and Probability Letters 1997;31:295-298.
  • Xu J-L. Simultaneous estimation of location parameters for sign-invariant distributions. Annals of Statistics 1997;25:2259-2272.

1996

  • Auvinen A, Rietbergen JBW, Denis LJ, Schroder FH, Prorok PC. Prospective evaluation plan for randomised trials of prostate cancer screening. J Med Screen 1996;3(2):97-104.
  • Baker SG. The analysis of categorical case-control data subject to nonignorable nonresponse. Biometrics 1996,52:362-369.
  • Baker SG. Searching for statistical significance; a misapplication of power. SOAP Newsletter. Summer 1996.
  • Berger V (ed). The Probability Problem Solver. Piscataway, NJ: Research and Education Association, 1996.
  • Freedman LS, Anderson G, Kipnis V, Prentice RL, Wang CY, Rossouw J, Wittes J, DeMets DL. Approaches to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative. Control Clin Trials 1996;17:509-25.
  • Goldfarb LG, Vasconcelos O, Platonov FA, Lunkes A, Kipnis V, Penn M, Vladimirtsev VA, Chabrashvili T, Alexeev VP, Hallet M, Gajdusek DC. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol 1996;39:500-506.
  • Kafadar K, Prorok PC. Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time. Computational Statistics and Data Analysis 1996;23:263-291.
  • Lanza E, Schatzkin A, Ballard-Barbash R, Corle D, Clifford C, Paskett E, Hayes D, Bote E, Caan B, Shike M, Weissfeld J, Slattery M, Mateski D, Daston C, for the PPT Study Group. The Polyp Prevention Trial II: dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev 1996;5:385-392.
  • Prorok PC, Potosky AL, Gohagan JK, Kramer BS. Prostate cancer screening: current issues. In: Miller AB (ed). Advances in Cancer Screening. Boston: Kluwer Academic Publishers, 1996;93-112.
  • Reeves MJ, Newcomb PA, Remington PL, Marcus PM, MacKenzie WR. Body mass and breast cancer: relationship between method of detection and stage of diagnosis. Cancer 1996;77:301-307.
  • Rosenfeld S. A spectral approach to the forward problem in GPS radio-occultation remote sensing (ray tracing, assimilation, tomography). National Environmental Satellite Data and Information Service, Technical Report #86, 1996.

1995

  • Baker SG, Freedman LS. Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst 1995;87:1137-1144.
  • Baker SG. Evaluating multiple diagnostic tests with partial verification. Biometrics 1995;51:330-337.
  • Baker SG. Marginal regression for repeated binary data with outcome subject to non-ignorable non-response. Biometrics 1995;51:1042-1052.
  • Brawley OW, Prorok PC, Gohagan J, Kramer BS. Principles of cancer screening. In: Haskell CM (ed). Cancer Treatment, Fourth Edition. Philadephia: WB Saunders, 1995;14-18.
  • Etzioni RD, Connor RJ, Prorok PC, Self SG. Design and analysis of cancer screening trials. Statisitcal Methods in Medical Research 1995;4:3-17.
  • Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Screening for ovarian cancer: epidemiological aspects, study design, target population, and patient acceptability. In: Lawton FG, Neijt JP, Swenerton KD (eds). Epithelial Cancer of the Ovary. London: BMJ Publishing Group, 1995;59-67.
  • Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute. Cancer 1995;75:1869-1873.
  • Green SB, Corle DK, Gail MH, Mark SD, Pee D, Freedman LS, Graubard BI, Lynn WR. Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol 1995;142(6):587-593.
  • Haffner SM, Newcomb PA, Mares-Perlman J, Marcus PM, Klein BEK, Klein R. Relationship of sex hormones to total and HDL cholesterol, and glycosylated hemoglobin in a population-based study of post-menopausal women. Am J Epidemiol 1995;142:925-934.
  • Hrabinski D, Hertz JL, Tantillo C, Berger V, Sherman AR. Iron repletion attenuates the protective effects of iron deficiency in DMBA-induced mammary tumors in rats. Nutr Cancer 1995;24(2):133-142.
  • Hymowitz N, Corle D, Royce J, Hartwell T, Corbett K, Orlandi M, Piland N. Smokers' baseline characteristics in the COMMIT trial. Prev Med 1995;24(5):503-508.
  • Iversen P, Madsen PO, Corle DK. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate: twenty-three year follow-up of a prospective ramdomized study. Scand J Urol Nephrol Suppl 1995;172:65-72.
  • Izmirlian G, Suchindran CM. Estimation of divergence measures from censored failure time data. Proceedings of the American Statistical Association, Biometrics Section 1995;427-432.
  • Krebs-Smith SM, Heimendinger J, Patterson BH, Subar AF, Kessler R, Pivonka E. Psychosocial factors associated with fruit and vegetable consumption. Am J Health Promotion 1995;10:98-104.
  • Krebs-Smith SM, Heimendinger J, Subar AF, Patterson BH, Pivonka E. Using food frequency questionnaires to estimate fruit and vegetable intake: association between the number of questions and total intakes. J Nutr Ed 1995;27:80-85.
  • Marcus PM, Newcomb PA, Young T, Storer BE. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Annals of Epidemiology 1995;5:303-309.
  • Newcomb PA, Klein R, Klein BEK, Haffner S, Mares-Perlman J, Cruickshanks KJ, Marcus PM. Association of dietary and lifestyle factors with sex hormones in postmenopausal women. Epidemiology 1995;6:318-321.
  • Newcomb PA, Storer BE, Marcus PM. Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Res 1995;55:4906-4909.
  • Patterson BH, Harlan LC, Block G, Kahle L. Food choices of Whites, Blacks, and Hispanics: data from the 1987 National Health Interview Survey. Nutr Cancer 1995;23:105-119.
  • Patterson BH, Zech LA, Swanson CA, Levander OA. An overview of selenium kinetics in humans. In: Subramaninan S, Wastney ME (eds). Kinetic Models of Trace Elements and Mineral Metabolism During Development. New York: CRC, 1995;241-264.
  • Pizov R, Brown RH, Weiss YS, Baranov D, Hennes H, Baker SG, Hirshman CA. Wheezing during induction of general anesthesia in patients with and without asthma: a randomized blinded trial. Anesthesiology 1995;82:1111-1116.
  • Reeves MJ, Newcomb PA, Remington PL, Marcus PM. Determinants of breast cancer detection among Wisconsin (United States) women, 1986-1990. Cancer Causes Control 1995;6:103-111.
  • Subar AF, Heimendinger J, Patterson BH, Krebs-Smith SM, Pivonka E, Kessler R. Fruit and vegetable intake in the US: the baseline survey of the Five A Day for Better Health Program. Am J Health Promotion 1995;9(5):352-360.
  • The COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. Am J Public Health 1995;85(2):183-192.
  • The COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): II. changes in adult cigarette smoking prevalence. Am J Public Health 1995;85(2):193-200.
  • Trentham Dietz A, Newcomb PA, Marcus PM, Storer BE: The association of body size and large bowel cancer risk in Wisconsin (United States) women. Cancer Causes Control1995;6:30-36.
  • Wacholder S, Schatzkin A, Freedman LS, Kipnis V, Hartman A, Brown CC. Re:"Can energy adjustment separate the effect of energy from those of specific macronutrients?" the authors reply (letter). Am J Epidemiol 1995;142:226.
  • White SN, Shao XY, Yu Z, Li ZC, Kipnis V. Cyclic mechanical fatigue of a feldspathic dental porcelain. Int J Prosthodont 1995;8:213-221.
  • White SN, Yu Z, Tom JFMD, Sangsurasak S, Furuichi R, Kipnis V. Effect of different luting agents on casting margin discrepancies in vivo. J Prosthet Dent 1995;74:25-33.
  • Xu J, Prorok PC. Nonparametric estimation of the post-lead time survival distribution of screen-detected cancer cases. Stat Med 1995;14:2715-2725.
  • Xu J-L, Yang GL. A note on a characterization of the exponential distribution based on a type II censored sample. Annals of Statistics 1995;23:769-773.
  • Yu Z, Strutz JM, Kipnis V, White SN. Effect of dynamic loading methods on cement film thickness in vitro. J Prosthodont 1995;4:251-256.

1994

  • Baker SG, Lindeman KS. The paired availability design: a proposal for evaluating epidural analgesia during labor. Stat Med 1994;13:2269-2278.
  • Baker SG. Composite linear models for incomplete multinomial data.Stat Med 1994;13:609-622. Software at http://library.wolfram.com/infocenter/MathSource/706/.
  • Baker SG. Regression analysis of grouped survival data with incomplete covariates: nonignorable missing-data and censoring mechanisms. Biometrics 1994;50:821-826.
  • Baker SG. Themultinomial-Poisson transformation. The Statistician 1994;43:495-504.
  • Brown CC, Kipnis V, Freedman LS, Hartman A, Schatzkin A, Wacholder S. Energy adjustment models for nutritional epidemiology: the effect of categorization. Am J Epidemiol 1994;139:323-338.
  • Connor RJ, Prorok PC. Issues in the mortality analysis of randomized controlled trials of cancer screening. Control ClinTrials 1994;15:81-99.
  • Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute. J Urol 1994;152:1905-1909.
  • Kafadar K, Prorok PC. A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials. Stat Med 1994;13:569-586.
  • Korn EL, Midthune DN, Chen TT, Rubinstein LV, Christian MC, Simon RM. Acomparison of two phase I trial designs. Stat Med 1994;13:1799-1806.
  • Kramer BS, Gohagan J, Prorok PC. NIH consensus 1994: screening.Gynecol Oncol 1994;55:S20-S21.
  • Lindeman KS, Baker SG, Hirshman CA. Interaction between halothane and thenonadrenergic, noncholinergic inhibitory system in porcinetrachealis muscle. Anesthesiology 1994;81:641-648.
  • Marcus PM, Newcomb PA, Storer BE. Early adulthood physical activity and colon cancer risk among Wisconsin women. Cancer Epidemiol Biomarkers Prev 1994;3:641-644.
  • Prorok PC, Gohagan J, Kramer B. The National Cancer Institute multi-screening trial. Canadian Journal of Urology 1994;4(Suppl 1):98-101.
  • Prorok PC. Screening studies. In Greenwald P, Kramer BS, Weed DL (eds).The Science and Practice of Cancer Prevention and Control. New York: Marcel-Dekker,1994;225-242.
  • Rodgers AB, Kessler LG,Portnoy B, Potosky A, Patterson BH, Tenney J, Mathews O. "Eat for Health": a supermarket intervention for nutrition and cancer risk reduction. Am J Public Health 1994;84:72-76.
  • Subar AF, Zeigler RG, Patterson BH, Ursin G, Graubard B. US dietary patterns associated with fat intake: the 1987 National Health Interview Survey. Am J Public Health 1994;84:359-366.
  • Wacholder S, SchatzkinA, Freedman LS, Kipnis V, Hartman A, Brown CC. Can energy adjustment separate the effect of energy from those of specific macronutrients? Am J Epidemiol 1994;140:848-855.
  • White SN, Ingles S, Kipnis V. Influence of marginal opening on microleakage of cemented artificial crowns. J Prosthet Dent 1994;71:257-264.

1993

  • Arsouman M, Otis L, Kipnis V, Levine D. Observations of the anterior loop of the inferior alveolar canal. Int J Oral Maxillofac Implants 1993;8:295-300.
  • Baker SG, Wax Y, Patterson BH. Regression analysis of grouped survival data: informative censoring and double sampling. Biometrics 1993;49:379-389.
  • Fagerstrom R, Healy J. The reliability of LEC telephone networks. IEEECommunications Magazine 1993;31:44-48.
  • Freedman LS, Midthune DN, Brown CC, Steele V, Kelloff GJ. Statistical analysis of animal cancer chemoprevention experiments.Biometrics 1993;49:259-268.
  • Freedman, LS, Parmar MKB, Baker SG. The design of observer agreement studies with binary observations. Stat Med 1993;12:165-179.
  • Kipnis V, Freedman LS, Brown CC, Hartman A, Schatzkin A, Wacholder S. Interpretation of energy adjusted models for nutritional epidemiology. Am J Epidemiol 1993;137:1376-1380.
  • Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993;119:914-923.
  • Kramer BS, Gohagen J, Prorok PC, Smart C. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal and ovarian cancers. Cancer 1993;71:589-593.
  • Mangels AR, Block G, Frey CM, Patterson BH, Taylor PR, Norkus E, Levander OA. The relative bioavailability to humans of ascorbic acid ingested as fruit, vegetable, or in synthetic form. J Nutr 1993;123:1054-1061.
  • Newcomb PA, Storer BE, Marcus PM. Cancer of the large bowel in women in relation to alcohol consumption: a case-control study in Wisconsin (United States). Cancer Causes Control 1993;4:405-411.
  • Patterson BH, Zech LA, Swanson CA, Levander O. Kinetic modeling of selenium in humans using stable isotope tracers. J Trace Elem Electrolytes Health Dis 1993;7:117-120.
  • Sinha R, Patterson BH, Mangels AR, Levander OA, Gibson T, Taylor PR, Block G. Determinants of vitamin E in healthy males. Epidem Biomarkers Prevention 1993;2:473-479.
  • Thompson FE, Patterson BH, Midthune DN, Krebs-Smith SM,Breen N, Tenney J, Kessler LG, Kahle L. Evaluation of the Meat and Poultry Interventions in the NCI-Giant Food Eat for Health Study. 1993.
  • Wax Y, Baker SG, Patterson BH. A score test for non-informative censoring using doubly sampled grouped survival data.Appl Stat 1993;42(1):159-72.
  • White SN, Kipnis V. The effect of adhesive luting agents on the marginal seating of cast restorations. J Prosthet Dent1993;69:28-31.
  • White SN, Kipnis V. The three-dimensional effect of adjustment and cementation on crown seating. Int J Prosthodont 1993;6:248-54.
  • Ziegler RG, Ursin G, Craft NE, Subar AF, Graubard BI, Patterson BH. Does beta-carotene explain why reduced cancer risk is associated with vegetable and fruit intake? new research directions. In: Bray GA, Ryan DH (eds). Pennington Center Nutrition Series, Vol 3. Vitamins and Cancer Prevention. Baton Rouge: LSU Press, 1993;352-371.

1992

  • Baker SG, Rosenberger WF, DerSimonian R. Closed-form estimates for missing counts in two-way contingency tables. Stat Med 1992;11:643-657.
  • Baker SG. A simple method for computing the observed information matrix when using the EM algorithm with categorical data. Journal of Computational and Graphical Statistics 1992;1:63-76.
  • Block G, Patterson BH, Subar A. Fruit, vegetables and cancer: a review of the epidemiologic evidence. Nutr Cancer 1992;18:1-29.
  • Feuer EJ, Hankey BF, Gaynor JJ, Wesley MN, Baker SG, Meyer JS. Graphical representation of survival curves associated with a binary non-reversible time dependent covariate. Stat Med 1992;11:455-474.
  • Freedman LS, Pee D, Midthune DN. The problem of underestimating the residual error variance in forward stepwise regression. The Statistician 1992;41:405-412.
  • Gail MH, Byar DP, Pechacek TF, Corle DK. Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Control Clin Trials 1992;13(1):6-21.
  • Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extra hepatic bile duct. histologic types, stage of disease, grade, and survival rates. Cancer 1992;70:1498-1501.
  • Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gall bladder, histologic types, stage of disease, grade, and survival rates. Cancer 1992;70:1493-1497.
  • Hulton MR, Levin DL, Freedman LS. Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr 1992;5:1084-1090.
  • Kipnis V. Bootstrap assessment of prediction in exploratory regression analysis. In: LePage R, Billard L (eds). Exploring the Limits of Bootstrap. New York: John Wiley, 1992;363-387.
  • Navazesh M, Mulligan RA, Kipnis V, Denny PC, Denny PA. Comparing whole saliva and mucin concentration in healthy caucasian young and aged adults. J Dent Res 1992;71:1275-1278.
  • Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-1575.
  • Patterson BH, Block G. Response to letter to the editor. Am J PublicHealth 1992;82:466.
  • Patterson BH, Kessler LG, Wax Y, Bernstein A, Light L, Midthune DN, Portnoy B, Tenney J, Tuckermanty E. Evaluation of a supermarket intervention: the NCI-Giant Food Eat for Health Study. Evaluation Rev 1992;16:464-490.
  • Patterson BH, Zech LA. Development of a model for selenite metabolism in humans. J Nutr 1992;122:709-714.
  • Prorok PC. Epidemiologic approach for cancer screening: problems indesign and analysis of trials. Am J Pediatric Hematology/Oncology 1992;14:117-128.
  • Reith LA, Fagerstrom RM, Kiss GD, Vogel EM, Wood WW, Yuce HH. Performance of ceramic-ferrule optical connectors. In: Proceedings of the 41st International Wire and Cable Symposium1992;792-800.
  • Subar AF, Heimendinger J, Krebs-Smith SM, Patterson BH, Kessler R, Pivonka E. A Baseline Study of Americans' Fruit and Vegetable Consumption. Rockville, MD: National Cancer Institute, National Institutes of Health. 1992.
  • Torri V, Simon R, Russek-Cohen E, Midthune D, Freidman M. Statistical model to determine the relationship of response and survival in patients with advanced ovarian cancer treated with chemotherapy. J Natl Cancer Inst 1992;84:407-414.
  • White SN, Yu Z, Kipnis V. The effect of seating force on film thickness of new adhesive luting agents. J Prosthet Dent 1992; 68:476-481.
  • Ziegler RG, Subar AF, Craft NE, Ursin G, Patterson BH, Graubard BI. Does beta-carotene explain why reduced cancer risk is associated with vegetable and fruit intake? Cancer Res 1992;52:2060S-2066S.

1991

  • Baker SG, Connor RJ, Prorok PC. Recent developments in cancer screening modeling. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds). Cancer Screening. Cambridge: Cambridge University Press,1991;404-418.
  • Baker SG, Freedman LS, Parmar MKB. Using replicate observations in observer agreement studies with binary assessments. Biometrics 1991;47:1327-1338.
  • Baker SG. Evaluating a new test using a reference test with estimated sensitivity and specificity. Communications in Statistics 1991;20:2739-2752.
  • Clark LC, Patterson BH, Weed DL, Turnbull BW. Design issues in cancer chemoprevention trials using micronutrients: application to skin cancer. Cancer Bull 1991;43(6):519-524.
  • Connor RJ, Prorok PC, Weed DL. The case-control design and the assessment of the efficacy of cancer screening. J Clin Epidemiol 1991;44:1215-1221.
  • Cummings KM, Sciandra R, Pechacek TF, Lynn WR, Corle D. Public attitudes regarding limits on public smoking and regulation of tobacco sales and advertising--10 U.S. communities,1989. MMWR 1991;40:344-345.
  • Danforth R, Otis L, Kipnis V, Ong SH, Voss R. Corrected TMJ tomography; effectiveness of alternatives to SMV tracing. Am J Orthod 1991;100:547-552.
  • Feuer EJ, Kessler LG, Baker SG, Triolo HE, Green DT. The impact of breakthrough clinical trials on survival in population based tumor registries. J Clin Epidemiol 1991;44:141-153.
  • Kipnis V. Evaluating the impact of exploratory procedures in regression prediction: a pseudosample approach. Comput Stat Data Anal 1991;12:39-56.
  • Levin DL. Cancer statistics, models and projections. In: McLaughlin JR, Morgan P, Mao Y (eds). Proceedings of the Canadian Cancer Projection Workshop, June 8-10, 1991. Toronto: Health and Welfare, Canada 1992:1-9.
  • Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds). Cancer Screening. Cambridge: Cambridge University Press,1991.
  • Murphy SB, Cohn SL,Craft AW, Woods WG, Sawada T, Castleberry RP, Levy HL, Prorok PC, Hammond GD. Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening: Do Children Benefit from Mass Screening for Neuroblastoma? Ca Cancer J Clin 1991;41(4):227-230.
  • Navazesh M, Kipnis V, Brightman VJ. Relationship between dysgenzia, oral health, saliva and task function. IADR/AADR Meeting, Acapulco, 1991.
  • Otis L, Kipnis V. Detection of approximal dental lesions using computer images. J Dent Res 1991;70:432.
  • Patterson BH, Block G. Fruit and vegetable consumption: national survey data. In: Bendich A, Butterworth CE (eds). Micronutrients In Health and In Disease Prevention. New York: Marcel Dekker, 1991;409-436.
  • Prorok PC, Byar DP, Smart CR, Baker SG, Connor RJ. Evaluation of screening for prostate, lung and colorectal cancers: the PLC trial. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds). Cancer Screening. Cambridge: Cambridge University Press, 1991;300-320.
  • Swanson CA, Patterson BH, Levander OA, Veillon C, Taylor PR, Helzlsouer K, McAdam PA, Zech LA. Human[74Se]selenomethionine metabolism: a kinetic model. Am J Clin Nutr 1991;54:917-926.

1990

  • Baker SG. A simple EM algorithm for capture-recapture data with categorical covariates (with discussion). Biometrics 1990;46:1193-1197.
  • Baker SG, Chu KC. Evaluating screening for the early detection and treatment of cancer without using a randomized control group. J Am Stat Assoc 1990;85:321-327.
  • Gail MH, Brinton LA, Byar DP, Corle DK, Schairer C, Mulvihill JJ. Response to letter by Dr. Stefanek. (letter). J Natl Cancer Inst 1990;82:879-82.
  • Graversen PH, Nielsen KT, Gasser TC, Corle DK, Madsen PO. Radical prostatactomy versus expectant primary treatment in stages I and II prostatic cancer: a 15-year follow-up. Urology 1990;36(6):493-498.
  • Mattson ME, Cummings M, Lynn WR, Giffen C, Corle D, Pechacek T. Evaluation plan for the Community Intervention Trial for Smoking Cessation (COMMIT). IQCHE1990-91;1:271-290.
  • Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on a workshop of the UICC project on evaluation of screening for cancer. Int J Cancer 1990;46:761-769.
  • Patterson BH, Block G, Rosenberger WF, Pee D, Kahle L. Fruit and vegetables in the American diet: data from the NHANES II survey. Am J Public Health 1990;80:1443-1449.
  • Prorok PC, Connor RJ, Baker SG. Statistical considerations in cancer screening programs. In: Smith JA (ed). The Urologic Clinics of North America. Early Detection and Treatment of Localized Carcinoma of the Prostate. Philadelphia: WB Saunders, 1990;17:699-708.
  • Zurawski VR, Sjovall K, Schoenfeld DA, Broderick SF, Hall P, Bast RC, Eklund G, Mattsson B, Connor RJ, Prorok PC, Knapp RC, Einhorn N. Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer. Gynecol Oncol 1990;36:299-305.

1989

  • Baker SG, Heidenberger K. Choosing sample sizes to maximize expected health benefits subject to a constraint on total trial costs. Med Decis Making 1989;9:14-25.
  • Baker SG. Innovations in screening: evaluating periodic screening without using data from a control group. In: Engstrom PF, Anderson P, Mortenson L (eds). Advances in Cancer Control VI. New York: Alan R. Liss, 1989:15-21.
  • Byar DP, Corle DK, Brown CC. Observations on acid phosphatase in the VACURG studies of prostatic cancer. In: Catalona WJ, Coffey DS, Karr JP (eds). Clinical Aspects of Prostate Cancer. New York: Elsevier Science, 1989;29-36.
  • DiMagno EP, Corle DK, O'Brien JF, Masnyk IJ, Go VOW, Aamodt R. Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 1989;64:1226-1234.
  • Fang K-T, Xu J-L. A class of multivariate distributions including the multivariate logistic. Journal of Mathematical Research and Exposition 1989;9:91-98.
  • Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81(24):1879-1886.
  • Kindman LA, Gilbert HS, Almenoff JS, Ginsberg H, Fagerstrom R, Teirstein AS. High-density lipoprotein cholesterol is reduced in patients with sarcoidosis. Am J Med 1989;86:376-378.
  • Kipnis V. Relevancy criterion for discriminating among alternative model specifications. In: 1989 Proceedings of the Symposium on the Interface: Computing Science and Statistics. American Statistical Association 1989;376-381.
  • Light L, Tenney J, Portnoy B, Kessler L, Rogers AB, Patterson BH, Matthews O, Katz E, Blair JE, Evans SK, Tuckermanty E. Eat for Health: a nutrition and cancer control supermarket intervention. Public Health Rep 1989;104:443-450.
  • Mattson ME, Boyd G, Byar D, Brown C, Callahan JR, Corle DK, Cullen JW, Greenblatt J, Haley NJ, Hammond SK, Lewtas J, Reeves W. Passive smoking on commercial airline flights. JAMA 1989;61:867-872.
  • Patterson BH, Levander OA, Helzlsouer K, McAdam PA, Lewis SA, Taylor PR, Veillon C, Zech LA. Human selenite metabolism: a kinetic model. Am J Physiol 1989;257 (Regulatory Integrative Comp Physiol 26):R556-R567.
  • Patterson BH, Piantadosi S. Endpoint identification: selection and ascertainment. In: Moon TE, Micozzi M (eds). Nutrition and Cancer Prevention. New York: Marcel Dekker, 1989;491-512.
  • Taylor PR, Schatzkin A, Patterson BH, Schiffman M, Albanes D. Clinical metabolic studies in cancer research. Prev Med 1989;18:194-202.
  • Xu J-L, Fang K-T. The expected values of zonal polynomials of elliptically contoured distributions. Acta Mathematicae Applicatae Sinica (English Edition) 1989;5:6-14.

1988

  • Baker SG, Laird NM. Regression analysis for categorical variables with outcome subject to nonignorable nonresponse. J Am Stat Assoc 1988;83:62-69.
  • Block G, Rosenberger WF, Patterson BH. Calories, fat, and cholesterol: intake patterns in the US population, by race, sex, and age. Am J Public Health 1988;78:1150-1155.
  • Byar DP, Corle DK. Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies. NCI Monogr 1988;7:165-170.
  • Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128(3):467-477.
  • DerSimonian R, Baker SG. Two-process models for discrete-time serial categorical response. Stat Med 1988;7:965-974.
  • Fagerstrom R, Thornton J. Basic statistics and their use in aging research. In: Kent B, Butler R (eds). Human Aging Research: Concepts & Techniques. New York: Raven Press, 1988;25-40.
  • Fang K-T, Xu J-L, Teng C-Y. Likelihood ratio criteria testing hypotheses about parameters of a class of matrix elliptically contoured distributions. Northeastern Math J 1988;4:241-252.
  • Kipnis V. A pseudosample approach to model discrimination in regression analysis. In: 1988 Proceedings of the Business and Economic Statistics Section of the American Statistical Association. American Statistical Association, 1988.
  • Kipnis V. Assessment of prediction procedures in multiple regression analysis. In: 1988 Proceedings of the Symposium on the Interface: Computing Science and Statistics. American Statistical Association 1988;458-63.
  • Liu L, Chaudhari N, Corle DK, Sherins RJ. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. Fertil Steril 1988;49(2):302-308.
  • Madsen PO, Graversen PH, Gasser TC, Corle DK. Treatment of localized prostatic cancer. radical prostatectomy versus placebo: a 15-year follow-up. Scand J Urol Nephrol Suppl 1988;110:95-100.
  • Patterson BH, Block G. Food choices and the cancer guidelines. Am J Public Health 1988;78:282-286.
  • Prorok PC. Mathematical models in colorectal cancer screening. In: Chamberlain J, Miller AB (eds). Screening for Gastrointestinal Cancer. Toronto: Hans Huber Publishers, 1988;45-51.
  • Prorok PC. Mathematical models of breast cancer screening. In: Day NE, Miller AB (eds). Screening for Breast Cancer. Toronto: Hans Huber Publishers, 1988; 95-104.

1987

  • Fang K-T, Xu J-L. Mills' ratio of multivariate normal distributions and spherical distributions. Acta Mathematicae Sinica 1987;30:248-257.
  • Fang K-T, Fan J-Q, Xu J-L. The distributions of quadratic forms of random idempotent matrices with their applications. Chinese Journal of Applied Probability and Statistics 1987;3:289-297.
  • Fang K-T, Xu J-L (eds). Statistical Distributions. Beijing: Science Press, 1987.
  • Kipnis V. Model selection and predictive assessment in multiple regression. In: 1987 Proceedings of the Statistical Computing Section of the American Statistical Association. American Statistical Association 1987;170-174.
  • Meier DE, Orwoll ES, Keenan EJ, Fagerstrom RM. Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. J Am Geriatr Soc 1987;35:189-197.
  • Patterson BH. The impact of screening and eliminating preexisting cases on sample size requirements for cancer prevention trials. Control Clin Trials 1987;8:87-95.
  • Piantadosi S, Patterson BH. A method for predicting accrual, cost, and paper flow in clinical trials. Control Clin Trials 1987;8:202-215.
  • Pinsker ISh, Kipnis V, Grechanovsky E. The use of conditional cut-offs in a forward selection procedure. Commun Stat-Theor Meth 1987;16:2227-2241.
  • Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive imipramine in the treatment of post-psychotic depression: a controlled trial. Arch General Psych 1987;44:533-539.
  • Xu J-L. Inverse Dirichlet distribution and its applications. Acta Mathematicae Applicatae Sinica 1987;10:91-100.

1986

  • Aron JL, Prorok PC. An analysis of the mortality effect in a breast cancer screening study. Int J Epidemiol 1986;15:36-43.
  • Chamberlain J, Day NE, Hakama M, Miller AB, Prorok PC. UICC workshop of the project on evaluation of screening programmes for gastrointestinal cancer. Int J Cancer 1986;37:329-334.
  • Connelly RR, Levin DL. Epidemiologie des Pankreaskarzinoms (Chapter 1.1). In: Beger HG, Bittner R (eds). Das Pankreaskarzinom. Berlin, Springer-Verlag, 1986:1-15.
  • Day NE, Baines CJ, Chamberlain J, Hakama M, Miller AB, Prorok P. UICC project on screening for cancer: report of the workshop on screening for breast cancer. Int J Cancer 1986;38:303-308.
  • Eisenkraft JB, Papatestas AE, Kahn CH, Mora CT, Fagerstrom R, Genkins G. Predicting the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1986;65:79-82.
  • Fang K-T, Xu J-L. The direct operations of symmetric and lower-triangular matrices with their applications. Northeastern Math J 1986;2:4-16.
  • IARC Working Group on Cervical Cancer Screening. Screening for squamous cervical cancer--the duration of low risk following negative results in cervical cytology tests: introduction. In: Hakama M, Miller AB, Day NE (eds). Screening for Cancer of the Uterine Cervix. IARC Scientific Publications No. 76, Lyon: International Agency for Research on Cancer, 1986;15-24.
  • IARC Working Group on Cervical Cancer Screening. Summary chapter. In: Hakama M, Miller AB, Day NE (eds). Screening for Cancer of the Uterine Cervix. IARC Scientific Publications No. 76, Lyon: International Agency for Research on Cancer, 1986;133-142.
  • IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986;293:659-664.
  • Levin DL, Gail MH, Kessler LG, Eddy DM. A model for projecting cancer incidence and mortality in the presence of prevention, screening, and treatment programs. In: Cancer Control Objectives for the Nation: 1985-2000. NCI Monographs #2, 1986;83-93.
  • Mason TJ, Prorok PC, Costlow RD. Conference on medical screening and biological monitoring for the effects of exposure in the workplace, part II. J Occup Med 1986;10:28.
  • Mason TJ, Prorok PC, Neeld WE, Vogler WJ. Screening for bladder cancer at the DuPont Chambers Works: initial findings. J Occup Med 1986;28:1011-1016.
  • Papatestas AE, Fagerstrom R, Aufses AH Jr. Association of tumor differentiation with hormone receptors and obesity in women with breast cancer. In: Angeli A, Barlow HL, Dogliotti L (eds). Endocrinology of the Breast: Basic and Clinical Aspects. New York: New York Academy of Sciences, 1986;550-552.
  • Patterson BH, Bilgrad R. Use of the National Death Index in cancer studies. J Natl Cancer Inst 1986;77:877-881.
  • Pinsker ISh, Kipnis V, Grechanovsky E. A recursive formula for the probability of occurrence of at least m out of N events. Am Stat 1986;40:275-276.
  • Pinsker ISh, Kipnis V, Grechanovsky E. Conditional cut-offs in the stepwise regression analysis (in Russian). In: The Design of Experiments. Moscow: Znanie, 1986;89-92.
  • Prorok PC, Connor RJ. Screening for the early detection of cancer. Cancer Invest 1986;4:225-238.
  • Prorok PC. Mathematical models and natural history in cervical cancer screening. In: Hakama M, Miller AB, Day NE (eds). Screening for Cancer of the Uterine Cervix. IARC Scientific Publications No. 76, Lyon: International Agency for Research on Cancer, 1986;185-196.
  • Stern RS, Weinstein MC, Baker SG. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol 1986;122:537-545.

1985

  • Blanke H, Cohen M, Karsch KR, Fagerstrom R, Rentrop KP. Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction. J Am College Cardiol 1985;5:827-831.
  • Chitkara U, Berkowitz GS, Levine R, Riden DJ, Fagerstrom RM, Chervenak FA, Berkowitz RL. Twin pregnancy: routine use of ultrasound examinations in the prenatal diagnosis of IUGR and discordant growth. Am J Perinatol 1985;2:49-54.
  • Fang K-T, Xu J-L, Zhang H-Q. Log-linear Models and Its Applications. Beijing: Academia Sinica, 1985.
  • Fang K-T, Xu J-L. Likelihood ratio criteria testing hypotheses about parameters of elliptically contoured distributions. Math in Economics 1985;2:1-19.
  • Greenwald P, Costlow R, Prorok P, Sondik EJ. Screening in the context of cancer control. In: Miller AB (ed). Screening for Cancer. New York: Academic Press, 1985;25-48.
  • Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. Evaluation of screening programmes for gynaecological cancer. Br J Cancer 1985;52:669-673.
  • Machac J, Horowitz SF, Fagerstrom R, Levine R, Goldsmith SJ. Characterization and automatic identification of ECG abnormalities using segmental multiharmonic Fourier analysis of gated blood pool scintigrams. Eur J Nuclear Med 1985;11:210-216.
  • Morrow JS, Levin DL, Kyle RA, Rosen SW. Placental proteins as tumor markers in human monoclonal gammopathies: results in 109 patients. Tumour Biology 1985;6:221-232.
  • Patterson BH, Smith PJ. Asymptotic and finite sample behavior of the time on test estimator under random censorship when lifetimes are not exponential. Commun Stat 1985;14:1643-1658.
  • Pinsker ISh, Kipnis V, Grechanovsky E. The use of the F-statistic in the forward selection regression algorithm. In: 1985 Proceedings of the Statistical Computing Section of the American Statistical Association. American Statistical Association, 1985;419-423.
  • Pinsker ISh, Trunov V, Kipnis V, Aidu E. Imitation estimators for quality of decisions (in Russian). In: Pinsker ISh (ed). Search for a Relationship and Estimation of Error. Moscow: Nauka, 1985;14-32.
  • Thompson TC, Izmirlian G, Lemon S, Truhlar DG, Mead CA. Consistent analytic representation of the two lowest potential energy surfaces for Li3, Na3, and K3. Journal of Chemical Physics 1985;82(12):5597-5603
  • Winawer SJ, Prorok P, Macrae F, Bralow SP. Surveillance and early diagnosis of colorectal cancer. Cancer Detect Prev 1985;8:373-392.

1984

  • Black MM, Hankey BF, Aron JL, Prorok PC. Possible immunological implications of an association between the stages of first and second independent breast cancer. Breast Cancer Research and Treatment 1984;4:95-104.
  • Byar DP, Corle DK. Analysis of prognostic factors for prostatic cancer in the VACURG studies. In: Denis L, Murphy G, Prout G, Schroder F (eds). Controlled Clinical Trials in Urologic Oncology. New York: Raven Press, 1984;174-189.
  • Chen JS, Prorok PC. Lead time estimation in a controlled screening program. Am J Epidemiol 1983;118:740-751.
  • Corle DK, Sears ME, Olson KB. Relationship of quantitative estrogen-receptor level and clinical response to cytotoxic chemotherapy in advanced breast cancer: an extramural analysis. Cancer 1984;54(8):554-561.
  • Ginsberg H, Grabowski GA, Gibson JC, Fagerstrom R, GoldblattJ, Gilbert HS, Desnick RJ. Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type 1 disease. Clinical Genetics 1984;26:109-116.
  • Prorok PC, Miller AB (eds.). Screening for Cancer I. - General Principles on Evaluation of Screening for Cancer and Screening for Lung, Bladder and Oral Cancer, Vol. 78. Geneva: UICC Technical Report Series, 1984.
  • Prorok PC, Chamberlain J, Day NE, Hakama M, Miller AB. UICC workshop on the evaluation of screening programmes for cancer. Int J Cancer 1984;34:1-4.
  • Prorok PC. Evaluation of screening programs for the early detection of cancer. In: Cornell RG (ed). Statistical Methods for Cancer Studies. New York: Marcel Dekker,1984;267-328.
  • Prorok PC. Methodologic issues in randomized controlled trials of screening. In: Prorok PC, Miller AB (eds). Screening for Cancer I. - General Principles on Evaluation of Screening for Cancer and Screening for Lung, Bladder and Oral Cancer, Vol. 78. Geneva: UICC Technical Report Series, 1984;18-28.
  • Rentrop KP, Feit F, Blanke H, Stecy P, Schneider R, Rey M, HorowitzS, Goldman M, Karsch K, Meilman H, Cohen M, Siegel S, Sanger J, Gorlin R, Fagerstrom R, Calhoun WF. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality inpatients with acute myocardial infarction. New Eng J Med 1984;311:1457-1463.

1983

  • Byar DP, Corle DK. Studies of acid phosphatase in prostatic cancer. In: Pavone-Macaluso M, Smith PH, (eds). Cancer of the Prostate and Kidney. Plenum Press,1983;159-166.
  • Chen JS, Prorok PC. An age dependent stochastic model of periodic screening: basic properties. Math Biosci 1983;65:69-91.
  • Chen JS, Prorok PC, Graff KM. An age dependent stochastic model of periodic screening: length bias at a prevalence screen. Math Biosci 1983;65:93-123.
  • Fagerstrom RM, Meeter DA. The design and analysis of a simulation: tolerance quantiles and random walk designs. Communications in Statistics -- Simulation and Computation 1983;12:541-558.
  • Fisher SG, Levin DL. The sexual knowledge and attitudes of professional nurses caring for oncology patients. Cancer Nurs 1983;6:55-62.
  • Kipnis V, Pinkser ISh. Imitation estimators of losses in autoregressive prediction (in Russian). VINITI Monograph 2404-83. Moscow: USSR Academy of Sciences, 1983.
  • Masnyk IJ, Sears M, Corle D. Serum bank for biological markers for breast cancer. J Natl Cancer Inst 1983;71:875-876.
  • Moskowitz G, Chalmers TC, Sacks HS, Fagerstrom R, Smith H. Deficiencies of clinical trials of alcohol withdrawal. Alcohol Clin Exp Res 1983;7:42-46.

1982

  • Austin FC, Boone CW, Levin DL, et al. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected cells. Cancer 1982;49:2034-2042.
  • Levin DL. Complicated strings made easy. Interface 101:105-109, National Institutes of Health, Division of Computer Research and Technology, March 1982.
  • Levin DL. Enhanced graphic string writing. Interface 101: 21-22, National Institutes of Health, Division of Computer Research and Technology, March 1982.
  • Prorok PC. Bounded recurrence times and lead time in the design of a repetitive screening program. J Appl Prob 1982;19:10-19.

1981

  • Baum ML, Anish DS, Chalmers TC, Sacks HS, Smith H, Fagerstrom RM. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. New Eng J Med 1981;305:795-799.
  • Byar DP, Corle DK, the VACURG. VACURG randomised trial of radical prostatectomy for stages I and II prostatic cancer. Veterans Administration Cooperative Urologic Research Group.Urology 1981;17(4 Suppl):7-11.
  • Byar DP, Corle DK. Randomized study of prostatic cancer (letter).Urology 1981;18:219-220.
  • Gilbert HS, Ginsberg H, Fagerstrom R, Brown WV. Characterization of hypocholesterolemia in myeloproliferative disease. Am J Med 1981;71:595-602.
  • Levin DL, Connelly RR, Devesa SS. Demographic characteristics of cancer of the pancreas: mortality, incidence, and survival. Cancer 1981;47(6):1456-1468.
  • Levin DL, Connelly RR. Epidemiology. In: Cohn C Jr, Hastings PR (eds). Pancreatic Cancer. Geneva, Switzerland: International Union Against Cancer, UICC, Technical Report Series 1981;57:5-12.
  • Prorok PC, Hankey BF, Bundy BN. Concepts and problems in the evaluation of screening programs. J Chronic Dis 1981;34:159-171.
  • Prorok PC, Mason TJ, Saccomanno G, Archer VE. Relationships between duration of sputum cytologic states and carcinogenic exposures among uranium miners. In: Gomez M (ed): Proceedings of the International Conference on Radiation Hazards in Mining: Control, Measurement and Medical Aspects. Kingsport, TN: Kingsport Press, 1981;957-961.

1980

  • Levin DL (ed). Cancer Epidemiology in the USA & USSR. US Dept of Health and Human Services, Public Health Service Publ. No. (NIH) 80-2044. Bethesda, MD, Govt Print Off, 1980:240.
  • Madsen PO, Maigaard S, Corle DK, Byar DP. Radical prostatectomy for carcinoma of the prostate: stages I and II. In: Rost A, Fiedler N (eds). Proceedings of the International Symposium on the Treatment of Carcinoma of the Prostate. Berlin: Urologische Klinik, Klinikum Steglitz, Freie Universitat. 1980;46-55.
  • O'Brien SJ, Gail MH, Levin DL. Correlative genetic variation in natural populations of cats, mice and men. Nature1980;288:580-583.
  • Schneiderman MA, Levin DL. Needs, problems, and prospects in cancer epidemiology. In: Levin DL (ed). Cancer Epidemiology in the USA & USSR. US Dept of Health and Human Services, Public Health Service Publ. No. (NIH) 80-2044. Bethesda, MD, Govt Print Off, 1980:25-28.

1979

  • Basu D, Fagerstrom R. A prior probability model for bioassay. In: Contributed Papers -- 42nd Session of the International Statistical Institute. International Statistical Institute, 1979;53-56.
  • Beilinson Y, Kipnis V. Short-term forecasting of industry production. Part II (in Russian), Moscow: USSR Central Statistical Board, 1979.
  • Kipnis V, Pinsker ISh. Forecasting short time series based on the chaotization principle (in Russian). In: Pinsker ISh (ed). Models. Algorithms. Decision Making. Moscow: Nauka, 1979;38-61.
  • Kipnis V. A method for construction of a quasi-linear predictor (in Russian). In: Pinsker ISh (ed). Models. Algorithms. Decision Making. Moscow: Nauka, 1979;62-90.
  • Kipnis V. The problem of forecasting time-series for small samples (in Russian). Scientific Letters on Statistics 1979;35:107-133.
  • Makey DG, Corle DK, Byar DP, Seal US. A computerized reference laboratory. Med Instrum 1979;13(1):46-50.
  • Prorok PC. Evaluation of the impact of screening on the natural history of disease. In: Brodie DR (ed). Screening and Early Detection of Colorectal Cancer, Consensus Development Conference Proceedings. DHEW Publ. No. (NIH) 80-2075, 1979;25-33.

1978

  • Beilinson Y, Kipnis V, Lifshitz N. Short-term forecasting of industry production. Part I (in Russian), Moscow: USSR Central Statistical Board, 1978.
  • Kipnis V, Pinsker ISh. Statistical forecasting of short time series (in Russian). VINITI Monograph 1900-78. Moscow: USSR Academy of Sciences, 1978.
  • Seal US, Doe RP, Byar DP, Corle DK. Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer 1978;42(4):1720-1729.

1977

  • Byar DP, Corle DK. Selecting optimal treatment in clinical trials using covariate information. J Chronic Dis 1977;30(7):445-459.
  • Chiazze L Jr, Levin DL, Silverman DT. Recent changes in estimated cancer mortality. In: Hiatt HH, Watson JD, Winsten JA (eds). Origins of Human Cancer, Cold Spring Harbor Conferences on Cell Proliferation, Vol 4. Maine: Cold Spring Harbor Laboratory, 1977:33-44.
  • Harada M, Mostofi FK, Corle DK, Byar DP, Trump BF. Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 1977;61(2):223-225.
  • Kipnis V. Chaotization principle approach to assessment of prediction (in Russian). In: Ryabushkin TV (ed). Questions of Mathematical - Statistical Analysis of Short-Term Processes. Moscow: CEMI USSR Academy of Sciences, 1977;87-93.
  • Kipnis V. Some problems of building time series predictive models for small samples (in Russian). Statistical Publications of the USSR Central Statistical Board 1977;12:131-139.
  • Levin DL, Baranovsky A. Cancers of other specified sites: melanoma of the skin and cancers of the eye, brain and cranial meninges, thyroid gland, bone, and connective tissue. In: Cancer Patient Survival Report No 5, 1976. US Dept of Health, Education, and Welfare, Public Health Service Publ. No. 77-992. Washington, DC: Govt Print Off, 1977:221-58.
  • Newell GR, Levin DL, Copley GD. Cancer epidemiology. In: Work TH (ed). Tracing the Patterns of Disease: The Role of Epidemiology and Biometry. US Dept of Health, Education, and Welfare, Public Health Service Publ. No. (NIH) 77-1285. Wash DC, Govt Print Off, 1977:25-38.
  • Schneiderman MA, Levin DL. Epidemiology of cancer and tobacco use: trends and trend indicators. In: Proceedings of the 3rd World Conference on Smoking and Health, Vol. 2. US Dept of Health, Education, and Welfare, Public Health Service Publ. No. (NIH) 77-1413. New York: Govt Print Off, 1977:73-84.
  • Thomas LB, Ackerman LV, McDivitt RW, Hanson TAS, Hankey BF, Prorok PC. Report of NCI Ad Hoc Pathology Working Group to review the gross and microscopic findings of breast cancer cases in the HIP study (Health Insurance Plan of Greater New York). J Natl Cancer Inst 1977;59:495-541.

1976

  • Chiazze L Jr, Silverman DT, Levin DL. The cancer mortality scare: problems of estimation using monthly data. JAMA 1976;236:2310-2312.
  • Kipnis V. Application of ARIMA models for forecasting time series (in Russian). Algorithms and Programs for Solving Economic Problems 1976;27:1-31.
  • Levin DL, Schneiderman MA. Cancer. In: Miller SS (ed). Symptoms: the Complete Home Medical Encyclopedia. New York: Thomas Y. Crowell, 1976:550-573.
  • Prorok PC. Cancers of the digestive system. In: Axtell LM, Asire AJ, Myers MH (eds.). Cancer Patient Survival, Report No. 5. DHEW Publ. No. (NIH) 77-992, 1976.
  • Prorok PC. The theory of periodic screening I: lead time and proportion detected. Adv Appl Prob 1976;8:127-143.
  • Prorok PC. The theory of periodic screening II: doubly bounded recurrence times and mean lead time and detection probability estimation. Adv Appl Prob 1976;8:460-476.
  • Seal US, Doe RP, Byar DP, Corle DK, the VACURG. Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer 1976;38(3):1108-1117.
  • Seal US, Doe RP, Byar DP, Corle DK, the VACURG. Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer 1976;38(3):1095-1107.

1975

  • No publications were produced in 1975.

1974

  • Levin DL, et al. Cancer Rates and Risks, 2nd ed. US Dept of Health, Education, and Welfare, Public Health Service Publ. No. (NIH) 75-691. Washington, DC: Govt Print Off, 1974;108.

1973

  • Levin DL, Connelly RR. Cancer of the pancreas: available epidemiologic information and its implications. Cancer 1973;31(5):1231-1236.
  • Schneiderman MA, Levin DL. Parallels, convergences, and departures in case-control studies and clinical trials. Cancer Res 1973;33:1498-1503.

1972

  • Arseneau JC, Sponzo RW, Levin DL, Schnipper LE, Bonner H, Young RC, Canellos GP, Johnson RE, DeVita VT. Nonlymphomatous malignant tumors complicating Hodgkin's Disease: possible association with intensive therapy. N Engl J Med 1972;287:1119-1122.
  • Epstein EH, Levin DL, Croft JD Jr, Lutzner MA. Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings. Medicine 1972;15(1):61-72.
  • Schneiderman MA, Levin DL. Trends in lung cancer: mortality, incidence, diagnosis, treatment, smoking, and urbanization. Cancer 1972;30(5):1320-1325.

1971

  • No publications were produced in 1971.

1970

  • Johnson RE, O'Conor GT, Levin D. Primary management of advanced lymphosarcoma with radiotherapy. Cancer 1970;25(4):787-791.

Back to top